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ABSTRACT 
 
 
THE IMPACT OF STORAGE TIME AND SEASONAL HARVESTING ON BIOMARKER 
LEVELS OF LESSERTIA FRUTESCENS 
In South Africa, it is estimated that approximately 70% of the population frequently make use 
of traditional medicinal plants for their health care needs.  The use of Lessertia frutescens by 
the various cultural groups in South Africa dates back to the earlier civilizations and 
continues to be used today to treat a multitude of ailments.  To get the best results from a 
medicinal plant, one would need to ensure that the crude material is of good quality through 
interventions like being properly grown, well dried and correctly processed.  This would add 
a measure of quality assurance, which will contribute towards the safety and efficacy aspect 
of herbal medicine.  
The aim of this study was to investigate what impact a particular season of harvest and the 
time in storage would have on the flavonoid and triterpenoid marker levels of Lessertia 
frutescens.  To achieve this, the following was investigated: (1) storage variation of Lessertia 
frutescens leaves by comparing the results obtained from the High Performance Liquid 
Chromatography (HPLC) analysis of the flavonoids and triterpenoids, (2) seasonal variation 
of Lessertia frutescens leaves by comparing the results obtained from the HPLC analysis of 
the flavonoids and triterpenoids, (3) leaf and stem variation of Lessertia frutescens by 
comparing the results obtained from HPLC analysis of the flavonoids and triterpenoids.  The 
hypotheses were: (1) the stored sample would indicate the same level of the biomarkers for 
the flavonoids and triterpenoids, as that of the freshly prepared sample, (2) the sample that 
was harvested during the summer season would indicate higher levels of the biomarkers of 
flavonoids and triterpenoids than the other three seasons, (3) the leaf sample would indicate 
the same level of the biomarkers for the flavonoids and triterpenoids, as that of the stem 
sample. 
An Agilent 1200 series HPLC was used for the determination of the flavonoids sutherlandin 
A and sutherlandin D as well as the triterpenoids sutherlandioside B and sutherlandioside D.    
Results show that for both sutherlandin A (summer: 3.67 ± 2.88 mg/ml; storage: 
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4.07 ± 2.88 mg/ml) and D (summer: 4.10 ± 1.06 mg/ml; storage: 4.25 ± 1.06 mg/ml) show 
significantly (P < 0.0001) higher concentrations in the case of the storage samples.  For both 
sutherlandioside B (summer: 3.01 ± 0.39 mg/ml; storage: 2.82 ± 0.39 mg/ml) and D 
(summer: 5.82 ± 0.42 mg/ml; storage: 4.66 ± 0.42 mg/ml) show significantly (P < 0.0001) 
higher concentrations in the case of the fresh summer samples.    
For the seasonal comparison, results show that for sutherlandin A 
(summer: 3.67 ± 12.49 mg/ml; autumn: 4.75 ± 12.49 mg/ml; winter: 4.23 ± 12.49 mg/ml; 
spring: 6.56 ± 12.49 mg/ml) show significantly (P < 0.0001) higher concentrations in the case 
of the spring sample.  For sutherlandin D (summer: 4.10 ± 10.32 mg/ml;  
autumn: 6.37 ± 10.32 mg/ml; winter: 5.25 ± 10.32 mg/ml; spring; 6.08 ± 10.32 mg/ml) show 
significantly (P < 0.0001) higher concentrations in the case of the autumn sample.  For both 
sutherlandioside B (summer: 3.01 ± 7.19 mg/ml; autumn: 2.15 ± 7.19 mg/ml; 
winter: 2.89 ± 7.19 mg/ml; spring: 1.47 ± 7.19 mg/ml) and D (summer: 5.82 ± 14.48 mg/ml; 
autumn: 3.33 ± 14.48 mg/ml; winter: 4.23 ± 14.48 mg/ml; spring: 2.50 ± 14.48 mg/ml) show 
significantly (P < 0.0001) higher concentrations in the case of the autumn sample. 
For the summer leaf/stem comparison, results show that for sutherlandin A (leaf: 3.67 ± 8.18 
mg/ml; stem: 4.67 ± 8.18 mg/ml) show significantly (P < 0.0001) higher concentrations in the 
case of the stem sample.  For the sutherlandin D (leaf: 4.10 ± 4.81 mg/ml; stem: 3.31 ± 4.81 
mg/ml) show significantly (P < 0.0001) higher concentrations in the case of the summer leaf 
sample.  For both the sutherlandioside B (leaf: 3.01 ± 4.24 mg/ml; stem: 3.62 ± 4.24 mg/ml) 
and D (leaf: 5.82 ± 0.42 mg/ml; stem: 5.80 ± 0.42 mg/ml) show significantly (P < 0.0001) 
higher concentrations in the case of the stem samples.   
Results demonstrate that the production of secondary metabolites are influenced by 
environmental factors like seasonal harvesting, as indicated by the variation in the chemical 
constituent composition of Lessertia frutescens depending on the season collected in.  
Moreover, the storage of Lessertia frutescens for a period of one year resulted in an increase 
of two of the four constituents being monitored.  There was slight variations in the chemical 
constituents, depending on whether the leaf or stem material of Lessertia frutescens was 
being used.  Finally, the type of chemical constituent being monitored was also important in 
the consideration of this study.  Therefore, this study can be seen as a starting point to further 
investigations of these aspects, which are of clinical, pharmacological and economic 
importance. 
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 CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 General information 
Since the beginning of time, the human species has relied on plant-based materials 
for the physical survival, health and wellbeing of the species (Chevallier, 1996; 
Bown, 2002; Springfield et al., 2005).  It has been over thousands of years that 
this reliance, on plant-based materials as a source of food, medicine, fuel, shelter 
and clothing, has led to the human species acquiring an evolved knowledge of the 
plant world surrounding them (Bown, 2002).  Not only were plants used as food 
for sustenance, but also for the medicinal benefits that certain of them offered 
(Chevallier, 1996).  According to Emboden (1997), during humankind‟s initial 
contact with plants, humans would have discovered that some of the plants were 
good for food, some that were poisonous and others that had mind altering effects, 
resulting in the relief of pain or disease.  This knowledge was handed down from 
generation to generation laying the foundations to various traditional based 
medicine systems throughout the world (Vogel, 1991).   
 
Due to growth in international trade, information about traditional medicinal 
plants, previously only available to the region‟s cultural groups, started becoming 
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more sought after throughout the world, leading to an increase in supply and 
demand (Van Staden, 1999; Joshi et al., 2004; Singh, 2008).  It is estimated that 
the world market for medicinal plants has grown annually at a rate of between 5% 
and 15%, and still continues to grow (Joshi et al., 2004).  The report from the 
World Health Organization (1998a) estimates that 80% of the people in the 
developing nations make use of traditional medicinal plants for their health care 
needs.  While according to Bown (2002), it is estimated that about 80% of the 
world‟s medicinal plants are still being harvested from the wild, causing concerns 
as many of the species are becoming rare due to over collection, slash and burn 
techniques, land clearance and other environmental issues.  In order to meet these 
demands, one would need to consider where future supplies would come from and 
therefore put in place measures to establish that what plant material consumers are 
purchasing, is really what it is being sold as (Bown, 2002). 
 
1.2 Problem: setting and background  
South Africa has a rich biodiversity of over 22 000 higher plant species, of which 
9 000 are indigenous, and represent 10% of the total of the world‟s plant species, 
occupying less than 1% of the earth‟s space (Goldblatt and Manning, 2000).  It is 
estimated that over 3000 indigenous plants are used and traded as traditional 
medicinal plants throughout Southern Africa, with 350 species being frequently 
used (Van Wyk et al., 1997; Van Wyk and Gericke, 2000).  Nevertheless, very 
little research has been carried out to verify the medicinal plants quality, safety 
and efficacy (Fennell et al., 2004a; Springfield et al., 2005; Johnson et al., 2007).  
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In South Africa, it is estimated that approximately 70% of the population 
frequently make use of traditional medicinal plants for their health care needs 
(Springfield et al., 2005).  Mander and Le Breton (2006) ascribe the use of 
traditional medicinal plants by such a large number of the population, to factors 
such as fairly easy availability of the plants, the relatively cheap price, that the 
traditional based knowledge concerning the use of plants as medicines is good, the 
lack of access to allopathic medicinal services and cultural pride.   
 
The use of Lessertia frutescens by the various cultural groups in South Africa 
dates back to the earlier civilizations (Van Wyk and Albrecht, 2008).  It continues 
to be used to treat a multitude of ailments affecting the integumentary, respiratory, 
cardiovascular, gastrointestinal, nervous, urinary, musculoskeletal, endocrine and 
immune systems (Van Wyk and Wink, 2004; Van Wyk, 2006; Van Wyk and 
Albrecht, 2008).  Traditionally, the leaves and stems of Lessertia frutescens were 
considered the parts to be used for their medicinal benefits.  Research verified that 
the leaves and stems do indeed yield the biologically active constituents, namely 
the secondary metabolites, which contribute to its medicinal properties (Moshe, 
1998; Van Wyk and Albrecht, 2008).  Lessertia frutescens contains the amino 
acids alanine, arginine, aspartic acid, asparagine, leucine, phenylanine, proline and 
tryptophan (Tai et al., 2004).  Moshe (1998) indicated the presence of elevated 
levels of protein-bound amino acids and free amino acids.  The non-protein amino 
acid L-canavanine, as well as pinitol and γ-aminobutyric acid (GABA) were 
isolated from Lessertia frutescens (Moshe, 1998). 
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More recently, four cycloartanol glycosides were isolated from the leaves of 
Lessertia frutescens namely; sutherlandiosides A, sutherlandiosides B, 
sutherlandiosides C and sutherlandiosides D (Fu et al., 2008).  In addition to the 
discovery of the four cycloartanol glycosides, another study led to the isolation of 
four flavonoid glycosides, also from the leaf material of Lessertia frutescens, 
namely; sutherlandin A, sutherlandin B, sutherlandin C and sutherlandin D (Fu et 
al., 2010).  Avula et al. (2010) developed an analytical method of determination 
of these four cycloartanol glycosides and four flavonoid glycosides. 
 
In South Africa in the past, and still applicable in the present, many of the 
traditional medicinal plants were harvested from the wild.  This procedure, 
however, is not sustainable in the current economic climate where the increased 
demand for medicinal plants serve not only a local, but international market as 
well (Van Staden, 1999; Street et al., 2008).  Small scale farming of traditional 
medicinal plant crops may be a way of addressing the growing needs (Van Staden, 
1999).  Van Wyk and Albrecht (2008) reported that cultivation and 
commercialization of Lessertia frutescens was started in 1990.   
 
In order to produce herbal medicines of quality, it is important to be able to 
correctly identify the crude material, thus adding a measure of quality assurance, 
which will contribute towards the safety and efficacy aspect of the herbal 
medicine (Joshi et al., 2004; Springfield et al., 2005).  To get the best results from 
a medicinal plant one would need to ensure that the crude material is of good 
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quality through interventions such as being properly grown, well dried and 
correctly processed (Chevallier, 1996; Fennell et al., 2004a; Street et al., 2008).  
Through the use of good agricultural methods that are well understood by those 
countries that have been growing food crops for many years, one could ensure 
quality, safety and efficacy of medicinal plant material (Fennell et al., 2004a).  
Fingerprinting could add further validation to the process by indicating the 
chemical profile that represents the complex makeup of chemical constituents that 
occur in each species.  This could be used as a marker for quality control 
(Springfield et al., 2005). 
 
Yanivie and Palevitch (1982), and Bopana and Saxena (2007) indicated that 
besides the genetic involvement, environmental factors also influenced the 
production of secondary metabolites.  According to McGimpsey et al. (1994) and 
Badi et al. (2003) the time of harvest is one of the most important factors that 
influence the quality and quantity of secondary metabolites.  Furthermore, Fennell 
et al. (2004a) have reported that despite its importance, storage of medicinal plant 
material and its effect on the constituents is very poorly researched.  
 
1.3 Lessertia frutescens – an indigenous medicinal plant 
In Southern Africa, predominantly in the drier parts of South Eastern Botswana, 
Southern Namibia, Lesotho and particularly in South Africa, Lessertia frutescens 
can be found growing naturally throughout these regions (Van Wyk et al., 1997; 
Van Wyk and Albrecht, 2008).  The geographical diversity of Lessertia frutescens 
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and its use by various cultural groups living within these geographical locations 
has resulted in numerous vernacular names for the medicinal plant (Van Wyk and 
Albrecht, 2008).  Lessertia frutescens is a traditional medicinal plant commonly 
referred to as cancer bush, duck plant, sutherlandia, ballon-pea, turkey flower 
(English); kankerbos, wildekeur, rooikeurtjie, kalkoenbos, belbos, keurtjie, 
gansies, blaasbossie, blaas-ertjie (Afrikaans); unwele (Zulu and Xhosa); insiswa 
(Zulu); musa-pelo, motlepelo, phethola (Sesotho and Setswana); lerumo-lamadi 
(North Sesotho), throughout South Africa (Van Wyk et al., 1997; Xaba and 
Notten, 2003; Powrie, 2004; Van Wyk and Albrecht, 2008).   
 
Lessertia frutescens is a shrublet (Figure 1 A), with greyish-green leaflets (Figure 
1 B), that can grow up to one metre in height (Van Wyk et al., 1997; Van Wyk 
and Gericke, 2000; Xaba and Notten, 2003; Manning, 2007).     
 
 
Figure 1: A:  Lessertia frutescens whole plant (Van Wyk and Albrecht, 2008). 
                B:  Lessertia frutescens leaves (Van Wyk and Albrecht, 2008). 
A B A 
B A 
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Van Wyk (2006) pointed out the complexity of the Lessertia species in that it has 
many regional forms and chemotypes.  Originally, the classification (Table 1) of 
the genus Sutherlandia was considered to be divided into six species as per the 
taxonomy described by Phillips and Dyer (1934).  The six species were named; 
Sutherlandia frutescens, Sutherlandia microphylla, Sutherlandia montana, 
Sutherlandia humilis, Sutherlandia speciosa and Sutherlandia tormenlosa (Philips 
and Dyer, 1934).  However, according to research done by Moshe (1998) there is 
only evidence to suggest two distinct species namely, Sutherlandia frutescens and 
Sutherlandia tormenlosa, while the others are considered to be subspecies of the 
two.  In 2000, Goldblatt and Manning proposed that the genus Sutherlandia be 
relocated under the genus Lessertia.  Although acknowledging that there may be 
merit in the reclassification, Van Wyk and Albrecht (2008) do question whether 
the inclusion of Sutherlandia into the Lessertia genus can truly be demonstrated 
from a morphological or genetic point of view.  The relocation resulted in the 
need to rename Sutherlandia tormentosa to Lessertia canescens (Van Wyk and 
Albrecht, 2008).  Sutherlandia frutescens became Lessertia frutescens, with 
reference being made to both names, indicating the same plant (Van Wyk., 2006; 
Van Wyk and Albrecht, 2008). 
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Table 1:  Taxonomic classification of Lessertia frutescens. 
Taxonomic categories 
Kingdom Plantae 
Division Magnoliophyta 
Class Magnohopsida 
Order Fabels 
Family Fabaceae (alt. Leguminosae) 
Genus Lessertia 
Species L. frutescens 
 
1.4 Botanical description 
Lessertia frutescens is a woody perennial shrublet that can grow up to one metre 
in height (Van Wyk et al., 1997; Van Wyk and Gericke, 2000; Xaba and Notten, 
2003; Manning, 2007).  Yet, according to Van Wyk and Albrecht (2008) Lessertia 
frutescens is a short-lived shrub that can grow between 0.2 to 2.5 metres in height.  
Some of its stems may grow along the ground, while others grow upright.  The 
shrub has compound petiolate, stipulate and pinnate leaves which are oval to 
oblong in shape, being longer than they are wide (Manning, 2007; Van Wyk and 
Albrecht, 2008).  The appearance of the leaflets vary in that they may range from 
hairless to slightly or completely hairy and have a slightly silvery/grayish green 
colour (Van Wyk et al., 1997; Van Wyk et al., 2000; Van Wyk et al., 2004; 
Manning, 2007).   
 
Red-orange coloured flowers (Figure 2), between 25-35mm in length, are 
produced during the spring to midsummer months of September, October, 
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November and December (Van Wyk et al., 1997; Van Wyk et al., 2000; van Wyk 
et al., 2004; Manning, 2007).  These flowers, after being pollinated, develop into 
large puffed up pods (Figure 2), papery and hairless in nature, wherein tiny black 
seeds develop (Van Wyk and Albrecht, 2008).  Figure 3 shows a commercial 
plantation growing in South Africa. 
 
 
Figure 2:  Lessertia frutescens showing the leaves, flowers and pods (Van Wyk, 2008). 
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Figure 3:  Commercial plantation of Lessertia frutescens (Van Wyk and Albrecht, 2008). 
 
1.5 Origin and distribution 
Lessertia frutescens, although now commonly found in many gardens throughout 
the world, was originally native to the drier parts of Southern Africa only (Van 
Wyk et al., 1997; Xaba and Notten, 2003).  Within South Africa, the shrub is 
prevalent in the Western Cape, up the West Coast into the Northern Cape, 
throughout the Western Karoo and also found in parts of the Eastern Cape (Xaba 
and Notten, 2003).  Figure 4 indicates the geographical locations of Lessertia 
frutescens. 
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Figure 4:  Map illustrating the distribution of Lessertia frutescens throughout South 
Africa (sahealthinfo.org). 
 
1.6 Traditional and current uses 
The use of Lessertia frutescens (whole plant material but mainly leaf and stem) as 
a traditional medicinal remedy has its origins dating back in history to where it 
was used by various cultural groups in South Africa; for instance the Khoi San, 
Nama people, Zulu, Xhosa and Cape Dutch (Van Wyk and Albrecht, 2008).  
Today, it is still considered a very popular medicinal plant and is used for the 
treatment of a multitude of health problems affecting the integumentary, 
respiratory, cardiovascular, gastrointestinal, nervous, urinary, musculoskeletal, 
endocrine and immune systems (Roberts, 1990; Van Wyk et al., 1997; Van Wyk 
and Gericke, 2000; Fernandes et al., 2004; Van Wyk and Wink, 2004; Ojewole, 
2008; Van Wyk and Albrecht, 2008).  
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The traditional use of Lessertia frutescens by the diverse cultural groups within 
South Africa, offers treatments for a variety of health problems (Table 2) 
manifesting within the various systems throughout the human body (Roberts, 
1990; Van Wyk, et al., 1997; Van Wyk and Gericke, 2000; Fernades et al., 2004; 
Van Wyk and Wink, 2004; Mills, et al., 2005; Ojewole, 2008; Van Wyk and 
Albrecht, 2008).  
 
Table 2:  Traditional and current use of Lessertia frutescens for health problems in 
relation to the major systems of the human body. 
Major systems of the human body Health problems  
Integumentary (skin) Minor burns, minor wounds and inflammation 
Respiratory  Colds and flu, bronchitis, coughs, asthma and 
tuberculosis 
Cardiovascular Varicose veins, piles and heart failure 
Gastrointestinal  Poor appetite, indigestion, gastritis, diarrhoea, 
constipation, dysentery and peptic ulcers 
Nervous Depression, anxiety, stress, shock and irritability 
Urinary Kidney problems, uterine troubles and urinary 
tract infections 
Musculoskeletal Arthritis, osteoarthritis, rheumatoid arthritis and 
general backache 
Endocrine  Good adaptogen and diabetes 
Immune Fever, chickenpox, tumors, wasting in aids, 
wasting in cancer, internal cancers and tonic 
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In recent years, there has been a lot of research being carried out concerning the 
use of Lessertia frutescens, these either confirming traditional uses or establishing 
new uses.  In this regard, recent in vitro and in vivo studies have shown anti-
diabetic, anti-proliferative, anti-inflammatory, antibacterial, anti-HIV, analgesic, 
anticonvulsant and antithrombotic activities (Van Wyk and Albrecht, 2008). 
 
1.7 Constituents of Lessertia frutescens 
Secondary metabolites in medicinal plants are referred to as active principles, 
bioactive compounds or more commonly as constituents (Mills and Bone, 2000; 
Singh, 2008).  Compared to primary metabolites, the secondary metabolites are 
not as abundant (Deswick, 2002).  These secondary metabolites are not there by 
chance but part of a plant‟s evolutionary process that contributes towards factors 
like, the plants defence mechanism, attraction of pollinators or as a colouring 
agent (Deswick, 2002; Gurib-Fakim, 2006; Street et al., 2008).  It is the impact 
these secondary metabolites have, from a pharmacological perspective, which is 
of interest for their use as medicines (Gurib-Fakim, 2006).               
 
Herbal preparations of Lessertia frutescens are mainly made from the leaves of 
the plant, although the twigs and stems are often included as these also contain the 
active ingredients (Van Wyk et al., 1997; Tai et al., 2004).  There are a number of 
constituents that are present in Lessertia frutescens namely, L-canavanine, 
alanine, arginine, aspartic acid, asparagine, leucine, phenylanine, proline, 
tryptophan, pinitol, GABA, flavonoids and triterpenoids (Bell, 1958; Snyders, 
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1965; Viljoen, 1969; Brummerhof, 1969; Bell et al., 1978; Moshe, 1998; Tai et 
al., 2004; Van Wyk and Albrecht, 2008; Fu et al., 2008; Avula et al., 2010).   
 
Research by Moshe (1998) revealed the presence of protein-bound and free amino 
acids in the leaves of the Lessertia genus.  These levels of protein-bound and free 
amino acids were recognized as being high, according to the authors (Moshe, 
1998; Van Wyk and Albrecht, 2008).  In another study, Sutherlandia frutescens 
leaves were used to analyse the presence of free amino acids that was 
commercially grown in different areas (Van Wyk et al. (unpublished); Van Wyk 
and Albrecht, 2008).  According to the authors, high levels of arginine, asparagine 
and proline were isolated from the plants analysed.  Van Wyk and Albrecht 
(2008) go on to indicate the importance of L-arginine present, as this constituent 
acts as an antagonist of L-canavanine, potentiating the anticancer activity.  
 
Although non-proteinogenic amino acids were discovered in the seeds of the 
Lessertia genus by Bell (1958) and Bell et al. (1978), it was the discovery of the 
presence of L-canavanine in the Lessertia genus leaves by Moshe (1998) that was 
of interest.  Tai et al. (2004) confirmed the presence of L-canavanine, alanine, 
arginine, aspartic acid, asparagine, leucine, phenylanine, proline and tryptophan in 
commercial samples.  Van Wyk and Albrecht (2008) highlighted the discovery of  
L-canavanine as the possible explanation for the anticancer effect of the Lessertia 
genus in traditional medicine.  There is documented evidence for the anticancer 
and antiviral activity of L-canavanine (Figure 5), as well as its effect on 
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retroviruses and influenza viruses (Green, 1988; Crooks and Rosenthal, 1994; 
Swaffar, 1995; Rosenthal, 1997; Bence et al., 2002).  
 
 
Figure 5:  Structure of chemical constituent - L-canavanine.  
 
The discovery of γ-aminobutyric acid (Figure 6) in the Lessertia genus possibly 
explains its use in cases relating to anxiety and stress (Van Wyk and Albrecht, 
2008).  GABA is considered an inhibitory neurotransmitter (Sia, 2004; Mills et 
al., 2005).  Van Wyk and Albrecht (2008) note some interesting traditional uses of 
Lessertia frutescens for depression, fits and shock which were indicated in the 
research carried out by Moteetee and Van Wyk (2007).  The Zulu and Tswana 
names for Lessertia frutescens are „insiswa‟ and „phetola‟ respectively meaning 
„the one that dispels darkness‟ and „it changes‟, both suggesting their inclination 
for use in stress related conditions (Van Wyk and Albrecht, 2008).  Ortega (2003) 
indicated the use of GABA (Figure 6) to inhibit tumor cell migration. 
 
 
Figure 6:  Structure of chemical constituent - γ-aminobutyric acid (GABA).  
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A cyclitol called ino-inicytol, commonly referred to as pinitol (Figure 7), was 
discovered in the leaves of the Lessertia genus by Snyders (1965) and later by 
Viljoen (1969) and Brummerhof (1969).  Moshe (1998) confirmed the presence of 
pinitol in the Lessertia genus samples by HPLC analysis.  The importance of 
pinitol as an anti-diabetic agent and in cachexia resulting from cancer and AIDS is 
well researched (Ostlund and Sherman, 1996; Bates et al., 2000).  
 
 
Figure 7:  Structure of chemical constituent – pinitol. 
 
Flavonoids were detected in the Lessertia genus by Moshe in 1998.  According to 
this study, the Lessertia genus leaves contained a minimum of at least six 
flavonoids.  Flavonoids may occur in a free state or as glycosides, two 
constituents known as the largest group of naturally occurring polyphenolic 
compounds (Evans, 1989).  The use of flavonoids for a variety of ailments can be 
attributed to the wide range of activities namely; antioxidant, anti-inflammatory, 
anti-allergic, anti-platelet, vasoprotective, antiviral, antimicrobial and anti-cancer 
(Evans, 1989; Mills and Bone, 2000).   
 
More recent research using the leaves of Sutherlandia frutescens led to the 
discovery of four cycloartanol glycosides (Figure 9)  were isolated from the leaves 
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of Lessertia frutescens namely; sutherlandiosides A, sutherlandiosides B, 
sutherlandiosides C and sutherlandiosides D (Fu et al., 2008).  In addition to this 
discovery, another study led to the isolation of four flavonoid glycosides (Figure 
8) namely; sutherlandin A, sutherlandin B, sutherlandin C and sutherlandin D (Fu 
et al., 2010).  Avula et al. (2010) developed an analytical method of determination 
of these four cycloartanol glycosides and four flavonoid glycosides. 
 
                                       
A B 
         
C     D 
 
Figure 8:  Structure of chemical constituents – sutherlandin A (A), sutherlandin B (B), 
sutherlandin C (C) and sutherlandin D (D). 
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A  B 
                       
C D 
 
Figure 9:  Structure of chemical constituents – sutherlandioside A (A), sutherlandioside 
B (B), sutherlandioside C (C) and sutherlandioside D (D). 
 
A safety study done on Lessertia frutescens by the Medical Research Council of 
South Africa, reported no signs of toxicity (Seier et al., 2002).  This study 
involved the monitoring of possible toxicity in adult male vervet monkeys, after 
consumption of the powdered leaf, over a period of three months.  The 
biochemical, haematological, physiological and physical variables were 
monitored for the purpose of the study and Seier et al (2002) concluded, that even 
at 9 times the recommended dose, no adverse effects were noted.  In a clinical 
(phase 1) trial involving adults with no known illnesses or allergic conditions, 
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participants were given 400mg capsules containing Sutherlandia leaf powder, 
twice daily, over a period of three months (Johnson et al., 2007).  The physical, 
vital, blood and biomarkers variables were used and Johnson et al (2007) 
indicated no toxicity from the use of Lessertia frutescens at a dose of up to 800mg 
per day.  Although there was no toxicity reported, there were minor side effects in 
some individuals ranging from occasional mild diarrhoea, dry mouth, mild 
diuresis and dizziness in patients presenting with cachexia (Mills et al., 2005).   
 
1.8 Methods of identification 
In order to ensure the quality, safety and efficacy of traditional plant medicines, 
regulatory guidelines were set up by the World Health Organization (WHO, 
2000).  Worldwide there would be a need to set up pharmacopoeias accurately 
recording the data for the quality, safety and efficacy of the country‟s traditional 
medicinal plants, as per these WHO‟s regulatory guidelines.  Most of these 
guidelines suggest macroscopic, microscopic and chemical profiling as a measure 
of ensuring quality control (Evans, 1989; BHP, 1996; WHO, 1998; Joshi et al., 
2004).  Joshi et al. (2004) also go on to mention the parameters into which these 
evaluations were divided.  
 
Macroscopic parameters used for evaluation are colour, odour, shape, size, taste, 
texture, amongst others, while in microscopy one would consider the microscopic 
inspection of the plant material (Evans, 1989; Joshi et al., 2004).  The limitations 
of the reliance on these methods as the only methods for evaluation are that the 
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sample may contain substitutes or adulterants that look like the authentic material.  
Adding chemical profiling as an evaluation technique allows for the chemical 
fingerprint of each plant to be established, thus ensuring that the crude material is 
authentic (Evans, 1989; BHP, 1996; WHO, 1998; Joshi et al., 2004; Springfield et 
al., 2005).  
  
The use of analytical techniques such as Gas Chromatography (GC) and High 
Performance Liquid Chromatography (HPLC) is effective in establishing quality 
control parameters (BHP, 1996; WHO, 1998; Joshi et al., 2004; Springfield et al., 
2005).  Springfield et al. (2005) also reiterated the use of HPLC as an effective 
analytical tool for „fingerprinting‟ and when this was combined with online UV 
spectrum detection via a diode array configuration, in order to „establish a code of 
practice for the quality control of herbal products‟.   HPLC-UV is recognized as a 
simple, specific and effective analytical method for profiling the active 
constituents in herbal medicines (Foukaridis et al., 1994; BHP, 1996; WHO, 
1998; Amabeoku et al., 2001; Springfield, et al., 2005).  With this in mind, the 
South African Traditional Medicines Research Group (SATMERG) was initiated 
within the School of Pharmacy at the University of the Western Cape (UWC), and 
by using the identification techniques of taxonomy, microscopy, Thin-layer 
Chromotography (TLC) and HPLC linked to a diode array detector (DAD), 
monographs for 60 traditional medicinal plants have been established (Springfield 
et al., 2005).   
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1.9 Factors influencing quality, safety and efficacy 
With the large majority of the world‟s population relying on traditional medicines 
for their health care needs, quality assurance of the basic material is essential in 
order to establish quality, safety and efficacy (Fennell et al., 2004a; Joshi et al., 
2004; Springfield et al., 2005; Johnson et al., 2007; Street et al., 2008., Avula et 
al., 2010).  Springfield et al. (2005) pointed out that the trade and use of 
traditional medicinal plants are largely unregulated.   
   
There are many factors that may influence the biological activity or chemical 
profile of traditional medicinal plants (Fennell et al., 2004a; Joshi et al., 2004; 
Street et al., 2008).  These may be grouped under intrinsic and extrinsic factors 
(Joshi et al., 2004).  Genetics would fall under the heading intrinsic, while 
cultivation, harvesting, drying and storage would be examples of extrinsic factors 
(Joshi et al., 2004). 
 
When considering choosing the correct plant material, factors such as the 
selection of the correct chemotype, as well as the identification of the correct plant 
species, are important when trying to establish quality, safety and efficacy (WHO, 
1998; Fennell et al., 2004a; Joshi et al., 2004; Springfield et al., 2005).  Joshi et 
al. (2004) notes the difficulty in identifying a species when a plant has various 
botanical names, depending on the region it is growing in. 
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Street et al. (2008) refers to the influences of industrialization on the 
environmental and water resources, namely contamination of these two and, thus 
the quality, safety and efficacy of the basic plant material from these areas. 
Factors like mining, industrial waste, dry sewage sludge, polluted waters, heavy 
metal contamination, pesticides, chemical fertilizers and microbial contaminants 
all contribute towards a negative impact on quality, safety and efficacy of the 
plant material (Naicker et al., 2003; Roychoudhury and Starke, 2006). 
 
Biological activity may also be influenced by factors like the plant‟s age, 
geographical harvest site, seasonal variation and growth conditions (Taylor et al., 
2003; Buwa and Van Staden, 2007).  Fennell et al. (2004a) also draw attention to 
other factors like harvesting practices and storage conditions.  Ramakrischnappa 
(2002) relates to factors like climate, drying and proper storage conditions often 
being neglected by the growers of traditional medicinal plants. 
 
Quite a few factors have so far been established as having a considerable 
influence on the quality, safety and efficacy of traditional medicinal plant material 
and all are considered important, but for the purpose of this study only the 
seasonal and storage conditions have been considered. 
   
1.10 Seasonal harvest influences on constituents 
The impact seasonal harvesting had on the constituents of a plant was an 
important factor for the various cultures throughout the world to consider, notably 
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taking into account the thousands of years of coexistence human beings have had 
with plants as a source of food and medicine (Chevallier, 1996; Taylor et al., 
2003; Shale et al., 2004; Buwa and Van Staden, 2007). 
 
In India, traditional healers advocated the decoction of Alstonia sholaris to be 
consumed only during the monsoon season, as it was less toxic to the consumer 
than when collected during the other seasons (Jagetia and Baliga, 2005).  In an in 
vitro study, the same authors (Jagetia and Baliga, 2005) explored the effect of 
seasonal variation on the anti-neoplastic activity and cytoxicity of Alstonia 
sholaris (Jagetia and Baliga, 2005).  According to the results of this study, 
samples had been collected during the monsoon, winter and summer seasons and 
showed a dose dependent increase in anti-neoplastic activity of Alstonia sholaris 
where the highest cell killing effect had been observed for the extract prepared 
from the summer collections, and the study had also demonstrated a marked 
difference in potency of anti-neoplastic activity of extracts prepared from the 
winter and monsoon season collections (Jagetia and Baliga, 2005). 
 
The production of secondary metabolites, besides being genetically controlled, is 
also influenced by environmental factors (Yanivie and Palevitch, 1982; Bopana 
and Saxena, 2007).  The above mentioned determinants, of which time of harvest 
is amongst the most important, are able to influence the quality and quantity of the 
metabolites (Badi et al., 2003).  According to Mc Gimpsey et al. (1994), a plant 
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during its flowering period yields a greater volume of essential oil compared to 
any other period, therefore indicating a preferred time of harvest. 
 
The relationship between oil composition, toxicity and seasonal changes were 
investigated in an in vivo study for Salvia libanotica (Farhat et al., 2001).  The 
leaves of Salvia libanotica from the four seasons were processed for extraction of 
the oils and compared.  High levels of camphor (12.3%), camphene (4.8%) and 
beta-thujone (1.9%) had been found in the winter (Farhat et al., 2001) extracts, 
indicating the highest levels of toxicity compared to the other seasons.  The least 
toxic extract was that of spring.  The highest yield of oil had been found during 
the dry summer months, conditions that where favourable to high oil production 
(Pitarevic et al., 1985).  Variations in the chemical composition of essential oils 
from Ocimum selloi were associated with the particular season of harvest (Moraes 
et al., 2002).  
 
The effects of seasonal variation on the central nervous system activity of 
Ocimum gratissimum essential oil was investigated by monitoring the 
pharmacological changes (Freire et al., 2006).  This was done by testing the sleep 
inducing activity that results from the use of the essential oils (Freire et al., 2006). 
Samples were collected that were representative of the four seasons.  The greatest 
effect had been obtained with the autumn preparation, and the least effect was 
observed with the winter preparation (Freire et al., 2006).  The autumn 
preparation contained 16.81% 1.8-cineole, in comparison with the higher amount 
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in winter of 33.61%.  The 1.8-cineole is a monoterpene which acts as a central 
nervous system (CNS) stimulant (Burkard et al., 1999; Umezu et al., 2001).  
Thus, it had been possible to suggest that the decrease in the amount of this 
compound facilitated an increased sleeping time.  
 
A correlation study was carried out considering the main active constituent for the 
traditional antifungal activity of Polygonom acuminatum and the season of the 
year.  The study concluded that the constituent, polygodial had been the most 
concentrated sequiterpene with antifungal behavior and this had been collected in 
autumn (Derita et al., 2009). 
 
Various studies confirm the correlation between season of harvest and 
constituents (Taylor et al., 2003; Shale et al., 2005; Buwa and Van Staden, 2007).  
According to Buwa and Van Staden (2007), bark samples collected during the 
summer months from Harpephyllum caffrum, yielded bioactive constituents that 
had a higher antibacterial activity than any of the other samples collected that 
were representative of the other three seasons.  The effect seasonal influence can 
have on constituent levels may be even more diversified.  A study done by De 
Vasconcelos et al. (1999) noted that there were variations in constituent levels of 
the essential oils from the Ocimum gratissimum leaves during day time.  The 
result indicated that sunlight has an influence on the production of eugenol (De 
Vasconcelos et al., 1999). 
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1.11 Duration of storage influences on constituents 
Regardless of the influence duration of time in storage may have on the 
pharmacological activity of medicinal plants, not much research has been done in 
this field worldwide, especially in Southern Africa (Fennell et al., 2004a).  An 
understanding of the factors that affect the constituent levels of medicinal plants 
are important as they would affect the plants efficacy in treatment of disease, and 
its cytotoxic activity (Fennell et al., 2004a). 
 
It is generally understood that there are several factors that may influence 
chemical changes of plant material being stored such as; temperature, light, pH 
and enzymes (Fennell et al., 2004a).  At the pre-storage stage, factors like drying 
heat, cooling and packaging help prevent the degradation (Fennell et al., 2004a).  
Other factors like cultivation, harvesting, drying and the duration of storage may 
also lead to degradation but this is not as easily detected visually or olfactorially. 
Therefore, scientific investigation would be the most suitable method (Fennell et 
al., 2004a; Joshi et al., 2004). 
 
The possible variation in chemical composition of dried plant material samples 
stored for many years under different storage conditions has been investigated 
(Houba et al., 1995).  Reference samples that were certified and stored under 
laboratory conditions for twenty years had shown no changes in the results for 
almost all elements analysed (Houba et al., 1995).  Samples obtained from a 
continuous inter-laboratory exchange program for dried material had shown 
 
 
 
 
27 
 
constant composition during storage, independent of the way the samples had 
been stored (Houba et al., 1995).  These authors also reported on lucerne samples 
that were stored in paper bags for four years under normal laboratory conditions 
and summer barley stored in sealed glass for thirteen years, this at room 
temperature.  The results of the elements had not changed significantly during 
storage and the same conclusion was made from a sample of tea leaves that had 
been stored for eight years in sealed glass bottles and thereafter for two years at 
-20°C (Houba et al., 1995).  Houba et al. (1995) concluded that dried plant 
samples could be stored for a very long time without any significant changes in 
their chemical composition and that storage conditions seemed of less importance 
(Houba et al., 1995). 
 
An in vitro study was conducted by Stafford et al. (2005) to determine the 
biological activity of nine frequently used medicinal plants of South Africa by 
monitoring the results after variations in storage times.  The nine plants 
investigated were Alepedia amatymbica, Leonotis leonurus, Drimia robusta, 
Vernonia colorata, Merwilla natalensis, Eucomis autumnalis, Bowiea volubilis, 
Helichrysum cymosum and Siphonochilus aethiopicus.  The 90 day old and the 
one year old material were assayed for antibacterial activity and COX-1 
inhibition.  Thin Layer Chromatography (TLC) fingerprints of fresh and stored 
extracts were generated in order to document chemical changes during storage 
(Stafford et al., 2005).  Results indicated that chemical breakdown had occurred 
during storage of certain species.  It also appeared that in some cases certain 
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compounds underwent degradation as a result of the drying process.  Compounds 
that had previously not been detected in the fresh extracts were found in the 
extracts stored for a year (Stafford et al., 2005). 
 
The major antibacterial compounds found in Leonotis leonorus appeared to be 
stable as they were found in the fresh, one and five year old material (Stafford et 
al., 2005).  A second group of antibacterial compounds were observed in the five 
year old material that had not been detected in the fresh and one year old material.  
This suggested that the quantities of those compounds might have been increasing 
as a result of storage (Stafford et al., 2005).  Extracts of Veronia colorata and 
Leonotis leonorus had shown an increase in activity against Escherichia coli after 
one year (Stafford et al., 2005).  The five year old Leonotis leonorus material had 
shown an increased antibacterial activity against all bacteria except Klebsiella 
pneumonia, against which it appeared to have lost activity.  Since then there had 
been an increase in the biological activity, as was observed with the antibacterial 
activity, it was deduced that the precursor was less active than the product of the 
chemical change, or the ageing process had resulted in greater proportions of the 
active compound.  Antibacterial compounds appeared to be either stable or 
converted into more active compounds during storage (Stafford et al., 2005). 
 
An interesting observation with regards to the anti-inflammatory bioassay results 
was that in most situations the water and ethanol extracts indicated an increased 
activity after storage (Stafford et al., 2005).  This study by Stafford et al. (2005) 
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concluded that ideally, the chemical composition of plant material, as well as its 
biological activity should be determined directly after drying.  Thus, the effect of 
drying and storage of plant material should be dealt with separately.  In some 
cases it appeared that higher levels of compounds had been extracted as a result of 
the drying process (Stafford et al., 2005).  The authors concluded that if a specific 
plant retained its activity for one to five years after harvesting then it would not be 
necessary to collect fresh material all the time but rather store the dried material 
until it was needed.  Stafford et al. (2005) did indicate that the effect of storage 
would be species-specific because the chemical composition of each species 
would be different and thus it would not simply be a matter of assuming one 
particular shelf-life recommendation could be applied to all plant material.  
 
In other research, phenolic compounds, gallic acid and gallotannins in Mangifera 
indica, were found to naturally decline during storage, which resulted in a loss of 
astringency (El Ansai et al., 1971; Kim Lounds-Singleton and Talcott, 2009; 
Lakshminarayana et al., 1970; Mitra and Balwin, 1997; Shale et al., 1975). 
 
1.12 Rationale for the use of Lessertia frutescens 
The rationale was motivated by the long history of the use of Lessertia frutescens 
by the various cultural groups in South Africa as a popular traditional medicinal 
plant to treat a variety of ailments (Roberts, 1990; Van Wyk et al., 1997; Van 
Wyk and Gericke, 2000; Fernandes et al., 2004; Van Wyk and Wink, 2004; 
Ojewole, 2008; Van Wyk and Albrecht, 2008).  Also that today, Lessertia 
 
 
 
 
30 
 
frutescens is still considered a very popular medicinal plant used for the treatment 
of a multitude of ailments (Roberts, 1990; Van Wyk et al., 1997; Van Wyk and 
Gericke, 2000; Fernandes et al., 2004; Van Wyk and Wink, 2004; Van Wyk and 
Albrecht, 2008).  
 
In recent years there has been a lot of research being carried out concerning the 
use of Lessertia frutescens, these either confirming traditional uses or establishing 
new uses.  The flavonoids and triterpenoids of Lessertia frutescens have been part 
of very recent research (Fu et al., 2008; Avula et al., 2010). 
 
The report from the World Health Organization (WHO) (1998a) that estimates 
that 80% of the people in the developing nations make use of traditional medicinal 
plants for their health care needs.  To get the best results from a medicinal plant 
one would need to ensure that the crude material is of good quality through 
interventions like being properly grown, well dried and correctly processed, and 
then validate this by scientific research to establish safety and efficacy data.  
 
1.13 Research design and rationale 
Chemical analysis was performed using the HPLC technique to create fingerprints 
of the flavonoids and triterpenoids of Lessertia frutescens plant material to 
investigate what impact, if any, the duration of storage and a particular season of 
harvest would have on the flavonoid and triterpenoid marker levels of Lessertia 
frutescens. 
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According to Joshi et al. (2004) chromatographic techniques and molecular 
markers are important in herbal drug technology.  The biologically active 
components; L-canavanine, GABA and pinitol were found in Sutherlandia 
frutescens by experimental analysis (Moshe, Van Wyk et al., 1997; Tai et al., 
2004).  Springfield et al. (2005) used High Performance Liquid Chromatography 
with diode array detection as a means of “fingerprinting” Chironia baccifera, to 
contribute to establishing quality standards for indigenous medicinal plants in 
South Africa.  In research done to provide chemical markers for Sutherlandia 
frutescens, phytochemical investigation led to the discovery of four flavonoids 
and four triterpenoids (Fu et al., 2008; Avula et al., 2010).     
 
1.13.1 Rationale for the type of preparation used 
Ethanolic extracts were chosen because it is a popular means of administering 
medicinal plants in the modern world (Mills, 1991; Mills and Bone, 2000).  In this 
way, soluble herbal constituents can be separated from the fibrous material (Mills, 
1991; Mills and Bone, 2000).  In addition, ethanol strength above 20% can ensure 
sterility, thus acting as a preservative, so increasing the shelf life of the extract 
(Mills, 1991; Mills and Bone, 2000).  The ethanol concentration also has an effect 
on the type of chemical constituents, which end up getting extracted (Mills, 1991; 
Mills and Bone, 2000).  Ethanol-water mixtures can be used to extract a variety of 
chemical constituents including flavonoids and triterpenoids. 
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1.13.2 Rationale for the monitoring of the flavonoids and triterpenoids 
Moshe (1998) reported that Lessertia frutescens leaves contained at least six 
flavonoids.  More recent research done by Fu et al. (2008) in order to establish 
other chemical constituents for Lessertia frutescens, resulted in the discovery of 
the four flavonoids; sutherlandin A, sutherlandin B, sutherlandin C, sutherlandin 
D and four triterpenoids; sutherlandioside A, sutherlandioside B, sutherlandioside 
C, sutherlandioside D.  Then, Avula et al. (2010) developed the first analytical 
method for the determination of these flavonoids and triterpenoids.   
 
1.13.3 Rationale for the use of High Performance Liquid Chromatography  
HPLC, is being increasingly used and it has become standard practice to use this 
technique as an important tool for qualitative assessment of various chemical 
constituents (Foukaridis et al., 1994; Springfield et al., 2005; Joshi, et al., 2007).  
HPLC is able to perform separation of chemical constituents within a relatively 
fast time and can detect low concentration levels (Harris, 2003).  There is also the 
added advantage of easily being able to repeat and reproduce experiments. 
 
1.14 Research questions 
Within this context, it can be hypothesized that further investigations into factors 
that ensure that the crude material is of good quality, would be of relevance and is 
beneficial in order to ensure safety and efficacy.  The questions that arose in the 
planning of this study were:  
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 Would a particular season show a greater yield of biomarker/s than any of 
the other seasons? 
 Which marker/s would most suitably represent Lessertia frutescens in 
monitoring the more favourable season of harvest?  
 Would the flavonoids and triterpenoids be suitable markers? 
 Would the quality of fresh dried Lessertia frutescens deteriorate while 
being stored after a period of one year? 
 Which marker/s would most suitably represent Lessertia frutescens in 
monitoring the impact of time in storage? 
 How would the constituent levels in the stems compare to those in the 
leaves? 
 
1.15 Aim of the study 
The aim of this study was to investigate what impact, if any, the duration of 
storage and a particular season of harvest would have on the flavonoid and 
triterpenoid marker levels of Lessertia frutescens. 
 
1.16 Objectives of the study 
 To investigate storage variation of Lessertia frutescens leaves by 
comparing the results obtained from the HPLC analysis of the flavonoids 
and triterpenoids. 
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 To investigate seasonal variation of Lessertia frutescens leaves by 
comparing the results obtained from the HPLC analysis of the flavonoids 
and triterpenoids. 
 To investigate leaf and stem variation of Lessertia frutescens by 
comparing the results obtained from the HPLC analysis of the flavonoids 
and triterpenoids. 
 
1.17 Hypotheses 
The following hypotheses were tested: 
 The stored sample would indicate the same level of the biomarkers for the 
flavonoids and triterpenoids, as that of the freshly prepared sample.  The 
null hypothesis states that there would be no changes in the storage 
variation of Lessertia frutescens leaves. 
 The sample that was harvested during the summer season would indicate 
higher levels of the biomarkers of flavonoids and triterpenoids than the 
other three seasons.  The null hypothesis states that there would be no 
changes in the seasonal variation of Lessertia frutescens leaves. 
 The leaf sample would indicate the same level of the biomarkers for the 
flavonoids and triterpenoids, as that of the stem sample.  The null 
hypothesis states that there would be no changes in the leaf and stem 
variation of Lessertia frutescens. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
 
2.1 Chemicals, reagents, materials and equipment 
The following chemicals, reagents, materials and items of equipment were used 
for the preparation and analysis of the Lessertia frutescens samples. 
 
2.1.1 Chemicals, reagents and materials 
Freshly harvested leaves of Lessertia frutescens (Ezibusisweni farm, Stellenbosch, 
South Africa); distilled water that was obtained from Durbell Pharmacy, 
manufactured by Reitzer Pharmaceuticals (Pty) Ltd, Johannesburg, South Africa; 
ethanol 99% obtained from Azanin Pharmaceuticals, manufactured by Huletts, 
Pietermaritizburg, South Africa; qualitative filter paper, (Whatman No. 40, 
Whatman, Kent, England); high vacuum grease (Dow Corning, Seneffe, 
Belgium); helium (99.95%, Afrox, Johannesburg, South Africa); acetonitrile - 
HPLC grade (Honeywell, Burdick and Jackson, Michigan, USA); methanol - 
HPLC grade (Thermo Scientific Pierce, Rocklands, USA); formic acid - HPLC 
grade (Sigma-Aldrich, St. Louis, USA); Quercetin - HPLC grade (Sigma-Aldrich, 
St. Louis, USA); 1ml glass vial (Anatech Instruments (Pty) Ltd, Cape Town, 
South Africa.   
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2.1.2 Equipment 
Ventilated oven (Memmert, model 854, Schwabach, Germany); rotary evaporator 
(Buchi, Labortechnik, Flawil, Switzerland); balance (Mettler, model PE 6000, 
Gottingen, Germany); freeze-drier (Virtis, Freeze Mobile model 125L, The Virtis 
Company Gardener, New York, USA); freezer (-85°C Lozone CFC Freezer, 
model U855360, New Brunswick Scientific, New Jersey, USA).  For the 
chromatographic analysis an Agilent 1200 series High Performance Liquid 
Chromatography (HPLC) system was used, the system is listed under HPLC 
analysis.  
 
2.2 Authentication, collection and preparation of plant material 
Ezibusisweni farm (Spier Wine Estate) was identified as the site for the collection 
of freshly harvested plant material of Lessertia frutescens.  The farm is located in 
Stellenbosch (33° 55‟ 43.88” South and 18° 48‟ 11.76” East), which is situated in 
the Western Cape Province of South Africa.  On this farm, a commercial 
plantation of Lessertia frutescens was being specifically grown for a company that 
produces herbal tinctures.  As part of the agreement between the supplier and 
purchasing company, no artificial fertilizers, pesticides or herbicides were to be 
used during the growing and harvesting of these plant crops.  Well matured cow 
manure was used during the growing phase and the plantation was watered three 
times weekly, specifically during the hot dry months of summer.  This particular 
Lessertia frutescens plantation was two years old. 
 
 
 
 
 
37 
 
2.2.1 Authentication of plant material 
For authentication of the plant, material was collected from Ezibusisweni farm 
during the summer month of January 2010.  The material was authenticated by the 
botanist and curator of the herbarium at the University of the Western Cape 
(UWC), Mr F Weitz, as Lessertia frutescens.  The specimen was dried, prepared 
as per herbarium guidelines and finally stored in the herbarium of the Biodiversity 
and Conservation Biology department at the University of the Western Cape, 
under voucher number UWC 6971. 
 
2.2.2 Collection of plant material 
After authentication was established, an area of 16 m² was demarcated, which had 
nine Lessertia frutescens plants growing within this space allocation on the 
Ezibusisweni farm.  Throughout the year, four sets of plant material samples were 
collected from this area, representative of the seasons; summer (January), autumn 
(April), winter (July) and spring (October), as listed in Table 3.  Each sample 
collected consisted of freshly harvested plant material (leaves, twigs and stems) 
from all nine Lessertia frutescens plants.  The first sample (subdivided as LF1A, 
LF1B and LF1C), was collected during the summer season of South Africa at 
10.00 am on the 29
th
 January, 2010.  The rest of the seasonal samples, 
representative of autumn (LF2), winter (LF3) and spring (LF4), were also 
collected at 10.00 am on the 29
th
 day of the indicated months.  Collection details 
such as the parts used, dates, times and weather conditions are indicated in 
Table 4.  All the samples were collected within the same year, 2010. 
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Table 3:  Plant material samples representative of the four seasons and their months of 
collection.  
Plant material sample  Abbreviation  Season  Month  
Lessertia frutescens 1A LF1A Summer January 
ᵃ Lessertia frutescens 1B LF1B Summer January 
ᵇ Lessertia frutescens 1C  LF1C Summer January 
Lessertia frutescens 2 LF2 Autumn April 
Lessertia frutescens 3 LF3 Winter July 
Lessertia frutescens 4 LF4 Spring October 
ᵃ Collected at the same time as LF1A and stored for one year.  
ᵇ Collected at the same time as LF1A and is representative of the twig and stem material. 
 
 
Table 4:  Plant material sample collection details. 
Sample Parts used Collection 
Date 
Collection 
time 
Weather 
conditions 
LF1A Leaves 29/01/2010 10 am Clear 
ᵃ LF1B Leaves 29/01/2010 10 am Clear 
ᵇ LF1C Twigs/stems 29/01/2010 10 am Clear 
LF2 Leaves 29/04/2010 10 am Misty 
LF3 Leaves 29/07/2010 10 am Raining 
LF4 Leaves 29/10/2010 10 am Misty 
ᵃ Collected at the same time as LF1A, stored for a year and prepared for HPLC analysis 
on 29/01/2011.   
ᵇ Collected at the same time as LF1A and is representative of the twig and stem material.  
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2.2.3 Preparation of plant material 
All freshly collected plant material was rinsed with distilled water to remove any 
foreign particles, as per Springfield et al. (2005), and then the leaf material was 
separated from the bits of twigs and stems.  Once sorted, the plant material was 
weighed and measured.  For the summer season sample (subdivided as LF1A, 
LF1B and LF1C), a total weight of 330g was calculated, which was made up of 
110g of twig and stem material for LF1C, and 220g leaf material.  The leaf 
material was equally divided to provide 110g of fresh plant material for LF1A and 
110g for LF1B.  For the autumn (LF2), winter (LF3) and spring (LF4) seasonal 
samples, only the leaf material was weighed, 110g for each sample.  All fresh 
material was dried in a ventilated oven at a temperature of 35°C for three days. 
 
In the case of the summer season sample (for the storage component of this 
study), LF1B was placed into an amber glass container, which was sealed with a 
lid and placed into a cupboard, at room temperature.  This was stored for one year, 
after which it was prepared and analyzed as per the preparation method for all the 
other samples.  
 
2.2.4 Preparation of ethanolic extract 
All the dried plant material samples were prepared as ethanolic extracts, done 
according to the information in the British Herbal Pharmacopoeia (BHP) (1993), 
the British Pharmacopoeia (BP) (1923) and the British Pharmaceutical Codex 
(BPC) (1968).   
 
 
 
 
40 
 
The preparation was done as follows:  
Dried plant material was weighed to measure a total of 50 g and placed into a one 
litre glass jar.  Then, 400ml of 45% (v/v) ethanol was prepared and added to the 
50 g of dried plant material.  The jar was sealed with a lid in order to prevent any 
loss of alcohol and placed in a dark cupboard, at room temperature, for 14 days 
(Mills, 1991; Mills and Bone, 2000).  Throughout the two week period, the 
mixture was hand stirred daily so as to turn the contents in order to facilitate the 
dissolution of the soluble constituents (Mills, 1991).  After the determined time 
(14 days), the liquid was drained from the marc (solid material left after 
extraction) and left to stand for a few hours until it settled, after which it was 
filtered using filter paper.  
 
The summer season sample was the first collected and thus the first to be prepared 
as an ethanolic extract.  While LF1A consisted of dried leaf material, LF1B 
consisted of dried twig and stem material.  They were prepared simultaneously.  
In turn, the leaf material for the autumn (LF2), winter (LF3) and spring (LF4) 
seasonal samples, were prepared as ethanolic extracts, as per the preparation 
method described in the paragraph above.  The last ethanolic extract prepared was 
that of LF1B after having being stored for one year.  
 
Once the filtration process was complete, the filtrate was transferred into round 
bottom flasks and rotary evaporated at a temperature of 40°C, until dry 
(Springfield, et al., 2005).  This was done in order to remove all traces of solvents 
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from the sample.  Once dried, the extract powder was removed from the round 
bottom flask, weighed to calculate yield and transferred into an amber glass bottle 
with a cap and frozen at -85°C in a freezer.  Storage in the freezer lasted for four 
weeks due to the freeze-drier being out of commission (for the sake of consistency 
and accurately replicating the method, all the other samples were also frozen for 
the four week period).  Then, the cap was removed and the amber glass bottle 
with the frozen extract was placed into the freeze-drier at -40°C for a period of 
four days.  Once this stage was completed the freeze-dried extract powder was 
removed and weighed to calculate yield.   
 
2.2.5 Preparation of the freeze-dried extract powder for HPLC analysis 
Freeze-dried extract powder was weighed (0.2g), placed into a 10ml glass vial and 
reconstituted with 12ml of 45% (v/v) ethanol.  A lid was placed on the vial.  The 
mixture was vortex-mixed for 2 minutes, after which an aliquot of 1ml was taken 
out and placed into a 1ml glass vial.  The above method was repeated to establish 
an HPLC analysis sample size of 12 (n=12).  This was done for all the seasonal 
samples, in the case of the summer sample (LF1A, LF1B and LF1C), autumn 
(LF2), winter (LF3) and spring (LF4).  These were labeled in the case of LF1A as; 
LF1A-1, LF1A-2, LF1A-3, LF1A-4, LF1A-5, LF1A-6, LF1A-7, LF1A-8, 
LFA1-9, LF1A-10, LF1A-11, LF1A-12.  The same labeling format was used for 
all other samples.  These HPLC samples were now ready to be placed in the auto 
loading sampler for HPLC analysis.  
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2.3 High Performance Liquid Chromatography (HPLC) analysis 
For the chromatographic analysis an Agilent 1200 series HPLC system was used 
to separate, identify and quantify compounds.  It was comprised of a degassing 
system (Agilent Technologies, system part no: G1322A, Tokyo, Japan); a 
quaternary pump (Agilent Technologies, system part no: G1311A, Waldbronn, 
Germany); an auto loading sampler (Agilent Technologies, system part no: 
G1329A, Waldbronn, Germany); a C18 Discovery
TM
 column 150mm x 4.60mm, 
5µm (Sigma-Aldrich, St. Louis, USA), coupled with a diode-array detector 
(Agilent Technologies, system part no: G1315B, Waldbronn, Germany), a 
fluorescence detector (Agilent Technologies, system part no: G1521A, 
Waldbronn, Germany) and an analyte fraction collector (Agilent Technologies, 
system part no: G164C, Waldbronn, Germany).  The whole setup was managed 
by the Agilent ChemStation software „online and offline‟ (Agilent Technologies, 
system part no: G2173-60101L, Waldbronn, Germany).   
 
2.3.1 HPLC method 
An Agilent 1200 series HPLC system was used for the chromatographic 
determination of the flavonoids, sutherlandin A (1) and sutherlandin D (2), as well 
as the triterpenoids; sutherlandioside B (3) and sutherlandioside D (4).  The 
analytical method applied was adapted from the method developed by Avula et al. 
(2010).  Ten microlitres (10µL) of sample were injected into the column to obtain 
the separation of peaks.  For the stationary phase, a C18 Discovery
TM
  
reversed-phase hydrophobic column (25mm x 4.6mm; 5µm particle size) was 
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used and the temperature was maintained at 25°C.  While the mobile phase 
consisted of: acetonitrile containing 0.1% formic acid (A), and distilled water 
containing 0.1% formic acid (B), at a flow rate of 1.000 ml/minute.  The 
following gradient elution was used to do the analysis: from 0 min, A:B (15%: 
85%) to A:B (65%: 35%)  over the period of 35 minutes.  Each run was followed 
by a 5 minute wash using 100% (A) and a 15 minute equilibration period, 
bringing the total run time to 55 minutes.  To ensure conditions remained the 
same, after every third sample, a wash phase was carried out using 100% (A).   
 
Table 5 lists the running times of the HPLC gradient and the composition of 
solvents.  The flavonoid and triterpenoid compounds were detected by ultraviolet 
(UV) at 260nm and 360nm, respectively, with the use of a diode-array detector, 
based on the retention times and UV spectra.  
 
Table 5:  Running times of HPLC gradient and composition of solvents. 
Time (min) A% (Acetonitrile) B% (Distilled water) 
0 15 85 
35 65 35 
35.1 100 0 
40 100 0 
40.1 15 85 
55 15 85 
A = Acetonitrile containing 0.1% formic acid.  
B = Distilled water containing 0.1% formic acid.   
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2.3.2 Validation of HPLC  
To validate the HPLC fractionation that was used, the following analytical 
parameters were used: precision, accuracy and linearity.  These parameters were 
selected from the European Medicine Agency (EMEA) (1994 and 1996) quality 
guidelines, which are the internationally accepted documents that determine the 
validation of analytical methods.  Quercetin (HPLC grade) and methanol (HPLC 
grade) were used as standards for control and calibration purpose. 
 
For the determination of the precision and accuracy of the assay, an intra-day and 
inter-day approach was used.  This was achieved by analysing three samples 
(n = 3) per day, over a period of three days.   
 
For the linearity of the assay, the correlation coefficient (R²) for the standard 
curve of the peak height (Y) versus the concentration (X) of the flavonoids and 
triterpenoids were calculated by analysing three samples (n = 3), diluted at five 
different concentrations.  Serial dilutions of the extract in 45% ethanol with 
distilled water were carried out to obtain 100%, 50%, 25%, 12.5% and 6.25%. 
 
2.4 Data and statistical analysis 
To interpret the results obtained from the analysis of the various samples by the 
HPLC method, statistical methods were used for data transformation and analysis.  
To determine the flavonoid and triterpenoid levels of the samples, data was 
entered into an Excel Spreadsheet (Microsoft Office Excel 2010, Redmond, 
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Washington, USA) computer software package, which was used for the raw data 
transformation and analysis.  The flavonoid and triterpenoid area versus 
concentration data was used to determine linear regression analysis, the precision 
and accuracy by an intra-day and inter-day approach analysis.   
 
Statistical evaluation was performed using the MedCalc statistical software 
(MedCalc version 12.3.0, Mariakerke, Belgium).  Normal distribution of data was 
checked by means of the Kolmogorov-Smirnov test.  Depending on the normal 
distribution, parametric (independent t test) or non-parametric (Mann-Whitney 
test) tests were applied.  Data were then expressed as mean ± standard deviation 
(SD) and 95% confidence intervals (CI).  For the calculation of correlations, 
Pearson correlations were performed.  A p-value of less than 0.05 was considered 
significant.   
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CHAPTER 3 
 
RESULTS  
 
 
3.1 Organoleptic characteristics  
The organoleptic characteristics of the plant materials were incorporated as some 
pharmacopoeias include the colour of the material as part of the monograph 
(European Pharmacopoeia, 2002a; European Pharmacopoeia, 2002b; European 
Pharmacopoeia, 2002c).  Upon visual inspection of the fresh and dried plant 
material, it was observed that the leaf material retained its silvery-green-grey 
appearance after being dried (Figure 10 B), but was lighter in colour compared to 
that of the fresh material (Figure 10 A).  The fresh twig and stem material 
(Figure 11 A) had a silvery-green-grey appearance but was a light brown colour 
after being dried (Figure 11 B).  While in the case of the ethanol extract, it was 
noted that the leaf material retained its silvery-green-grey appearance while 
submerged in the solvent, and that the solvent took on a yellowish-brown 
appearance (Figure 12).  In the case of the stored dried leaf material, it appeared 
slightly more yellow in colour (Figure 10 C).  Both the rotary evaporated and the 
freeze-dried extract powders were dark brown in appearance.  The results of the 
organoleptic characteristics of the plant material are shown in Table 6. 
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In the literature, the bitter taste and the use of Lessertia frutescens as a bitter tonic 
is often mentioned (Roberts, 1990; Van Wyk et al., 1997; Van Wyk and Wink, 
2004; Van Wyk, 2008).  The characteristic bitter taste and strong bitter aromatic 
smell of the dried material gave the impression of being much stronger in the 
dried material than that of the fresh material.  The characteristic bitter taste was 
definitely stronger in the ethanol extract, than that of the fresh or dried material.  
In the case of the rotary evaporated and freeze-dried extract powders, both were 
much stronger tasting than either the fresh, dried or ethanolic extract comparisons.    
 
Table 6:  Organoleptic characteristics of Lessertia frutescens, visual identification 
details.  
ᵃ 5 g of material was placed against a white background and its colour observed.   
ᵇ 5 ml of liquid was placed in a white porcelain dish and its colour observed. 
Sample Appearance 
ᵃ Fresh leaf material Silvery-green-grey 
ᵃ Dried leaf material Slightly lighter silvery-green-grey 
ᵃ Stored dried leaf material Slightly yellowish 
ᵃ Fresh twig and stem material Silvery-green-grey 
ᵃ Dried twig and stem material Light brown 
ᵇ Ethanol extract Yellowish-brown 
Rotary evaporated extract powder Dark brown 
Freeze-dried extract powder Dark brown 
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Figure 10: A:  Fresh leaves of Lessertia frutescens. 
                   B:  Dried leaves of Lessertia frutescens. 
                   C:  Stored dried leaves of Lessertia frutescens. 
 
A 
B 
C 
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Figure 11: A:  Fresh twig and stem material of Lessertia fruescens. 
                   B:  Dried twig and stem material of Lessertia fruescens. 
 
 
 
Figure 12:  Ethanolic extract of Lessertia frutescens in a porcelain dish. 
 
A 
B 
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3.2 Yield of plant preparation and extraction 
The drying of the plant material reduced the weight of the fresh leaf material by 
an average of 52.3%, which produced an average yield of 52.1 g per sample.  
However, in the case of the twig and stem material, drying reduced the weight of 
the fresh material by only 31.8%, to produce a yield of 75 g dried material.  The 
average weight and percentage yields after drying are presented in Table 7.   
 
Table 7:  Average yields of Lessertia frutescens leaves, twigs and stem material after 
drying, in a ventilated oven at 35°C, for three days.  Average was calculated for leaf 
material only. 
Sample Parts used Fresh material  
 
(g) 
Yield of dried 
material  
(g) 
Yield of dried 
material 
(%) 
LF1A Leaves 110  50.5  45.9 
LF1B Leaves 110  51  46.4 
LF2 Leaves 110  53  48.2 
LF3 Leaves 110  54  49.1 
LF4 Leaves 110  52  47.3 
Average 52.1  47.4 
 
LF1C Twigs/stems 110  75  68.2 
 
The separation of ethanolic extract from the marc (solid material left after 
extraction) reduced the volume of liquid by an average of 30.2%, which produced 
an average yield of 279.2 ml per sample.  In the case of the twig and stem 
material, the separation reduced the volume of liquid by 35%, to produce a yield 
of 260 ml ethanolic extract.  There was no significant difference in the yield 
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between summer, autumn, winter and spring extractions.  The lowest yield was 
that of the summer sample (LF1A), being 68.5% and the highest yield was that of 
spring, 71%, in comparison with the average of 69.5%.  The average volume of 
liquid and percentage yields after separation are presented in Table 8.   
 
Table 8:  Average volume of liquid and percentage yields after separation of the 
ethanolic extract from the marc.  Average was calculated for leaf material only. 
Sample Parts used Dried 
material  
(g) 
Ethanol 
material  
(ml) 
Yield on 
separation  
(ml) 
Yields on 
separation  
(%) 
LF1A Leaves 50  400  274  68.5 
LF1B Leaves 50  400  276  69 
LF2 Leaves 50  400  280  70 
LF3 Leaves 50  400  282  70.5 
LF4 Leaves 50  400  284  71 
Average 279.2  69.8 
 
LF1C Twigs/stems 50  400  260  65 
 
The rotary evaporation of the ethanolic extract made from 50 g of leaf matter 
produced an average of 3.99 g of extract powder, which was an average yield of 
7.98%.  For the twig and stem material, 3.80 g was produced, reflecting a yield of 
7.60%.  No significant difference was noted in the yield between summer, 
autumn, winter and spring extractions.  The lowest yield was that of the summer 
sample (LF1A), being 7.88% and the highest yield was that of winter and spring, 
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8.04%, in comparison with the average of 7.98%.  Table 9 indicates the average 
weight and percentage yields after rotary evaporation. 
 
Table 9:  Average yields of Lessertia frutescens leaves, twigs and stem material, after 
rotary evaporation of the ethanolic extracts, at 40°C, for three days.  Average was 
calculated for leaf material extracts only.  
Sample Parts used Dried 
material  
(g) 
Extract 
powder  
(g) 
Loss on 
evaporation  
(g) 
Yield  on 
separation  
(%) 
LF1A Leaves 50  3.94  46.06  7.88 
LF1B Leaves 50  3.99  46.01  7.98 
LF2 Leaves 50  3.99  46.01  7.98 
LF3 Leaves 50  4.02  45.98  8.04 
LF4 Leaves 50  4.02  45.98  8.04 
Average 46.01  7.98 
 
LF1C Twigs/stems 50  3.80  46.20  7.60 
 
3.3 HPLC analysis 
The calibration curve of the HPLC analysis for the leaf material indicated a linear 
correlation between peak area and concentration in the range of 0.0104125 to 
0.166 g/ml.  This was described by the regression equation being 
Y = 166442 X + 3584.1 and the correlation coefficient of R² = 0.9812.  The 
results from the HPLC analysis for accuracy of the summer sample, as an 
example, are presented in Figure 13.   
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Figure 13:  Calibration curve and linear regression line for the determinations of 
the respected concentrations of Lessertia frutescens leaf material. 
 
The calibration curves for the flavonoids (sutherlandin A and sutherlandin D) and 
triterpenoids (sutherlandioside B and sutherlandioside D) showed the following 
regression equations and correlation coefficients (R²) between peak area and 
concentration depicted in Table 10 and Figures 14 to 17, where Y = peak area and 
X = concentration. 
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Figure 14:  Calibration curve and linear regression line for the determinations of 
the sutherlandin A concentrations in Lessertia frutescens. 
 
 
 
 
Figure 15:  Calibration curve and linear regression line for the determinations of 
the sutherlandin D concentrations in Lessertia frutescens. 
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Figure 16:  Calibration curve and linear regression line for the determinations of 
the sutherlandioside B concentrations of Lessertia frutescens.  
 
 
 
Figure 17:  Calibration curve and linear regression line for the determinations of 
the sutherlandioside D concentrations in Lessertia frutescens. 
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Table 10:  Regression equation and correlation efficient for sutherlandin A, sutherlandin 
D, sutherlandioside B and sutherlandioside D. 
Chemical constituent Regression equation Correlation coefficient (R²) 
Sutherlandin A Y = 40418 X + 981.66 0.9818 
Sutherlandin D Y = 51796 X + 1258.1 0.9805 
Sutherlandioside B Y = 29160 X + 492.52 0.9793 
Sutherlandioside D Y = 45065 X + 852.25 0.9801 
 
The results for the intra- and inter-day precision of the HPLC analysis are shown 
in Table 11.  These were achieved by injecting 10µL into the column, 
corresponding to a concentration of 0.166 g/ml of the extracts.  Results are 
expressed as mean ± SD.  The average intra-day precision was 1789.96 ± 16.25 
mAUF for sutherlandin A, 1549.58 ± 525.10 mAUF for sutherlandin D, 
1810.35 ± 30.00 mAUF for sutherlandioside B and 2600.65 ± 34.56 mAUF for 
sutherlandioside D.  While for the average inter-day precision was 
1789.95 ± 16.49 mAUF for sutherlandin A, 1640.84 ± 482.30 mAUF for 
sutherlandin D, 1810.36 ± 34.41 mAUF for sutherlandioside B and 
2600.65 ± 42.48 mAUF.    
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Table 11:  Intra- and inter-day precision of samples for the validation of the HPLC 
method of the constituents, sutherlandin A, sutherlandin D, sutherlandioside B and 
sutherlandioside D. 
Chemical 
constituent 
Intra-day 
(mAUF) 
(mean ± SD) 
(n=3) 
Inter-day  
(mAUF) 
(mean ± SD) 
(n=3) 
 Day 1 Day 2 Day 3  
Sutherlandin  
A 
1789.07 ± 22.11 1789.47 ± 17.62 1791.33 ± 9.02 1789.95 ± 16.49 
Sutherlandin  
D 
1571.07± 609.41 1822.72± 365.65 1254.94± 600.23 1640.84± 482.3 
Sutherlandioside 
B 
1802.21 ± 30.21 1796.30 ± 17.40 1832.55 ± 42.38 1810.36 ± 34.41 
Sutherlandioside 
D 
2615.93 ± 41.51 2619.45 ± 20.08 2566.58 ± 42.10 2600.65 ± 42.48 
 
3.4 Flavonoid and triterpenoid profile of the ethanolic extracts 
Retention times (mins) were used in order to identify individual flavonoids 
(sutherlandin A and sutherlandin D) and triterpenoids (sutherlandioside B and 
sutherlandioside D) (Figure 18), while the peak areas milli-Absorbance Units 
(mAUF) were the parameters used to determine the level of flavonoids and 
triterpenoids in the samples (Table 12).  An example of a chromatogram 
fingerprint representative of the summer season is presented in Figure 19 A and 
20 A.  These peak areas had average retention times of 9.186 ± 0.024 min, 
13.128 ± 0.030 min, 35.559 ± 0.048 min and 36.139 ± 0.042 min; the autumn 
season (Figure 19 B) of  9.234 ± 0.005 min, 13.171 ± 0.008 min, 35.574 ± 0.018 
min and 36.141 ± 0.002 min; the winter season (Figure 19 C) of 9.243 ± 0.005 
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min, 13.169 ± 0.006 min, 35.651 ± 0.002 min and 36.232 ± 0.003 min; the spring 
season (Figure 19 D) of 9.249 ± 0.013 min, 13.196 ± 0.013 min, 35.619 ± 0.030 
min and 36.200 ± 0.021 min; the stem sample (Figure 20 B) of 9.261 ± 0.010 min, 
13.227 ± 0.011 min, 35.615 ± 0.020 min and 35.860 ± 1.152 min; the storage 
sample (Figure 20 C) of 9.260 ± 0.033 min, 13.208 ± 0.029 min, 35.611 ± 0.042 
min and 36.185 ± 0.041 min.   
 
 
Figure 18:  HPLC chromatogram for the summer sample (LF1A) indicating retention 
times of sutherlandin A, sutherlandin D, sutherlandioside B and sutherlandioside D. 
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Figure 19: Sample HPLC chromatograms from material collected in different seasons 
                  A:  HPLC chromatogram for the summer sample (LF1A)  
                  B:  HPLC chromatogram for the autumn sample (LF2) 
                  C:  HPLC chromatogram for the winter sample (LF3) 
                  D:  HPLC chromatogram for the spring sample (LF4) 
Peaks indicate the following: 
a: sutherlandin A; b: sutherlandin D; c: sutherlandioside B; d: sutherlandioside D  
A 
B 
C 
D 
a b c d 
a b c d 
a b c d 
a b c d 
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Figure 20: Sample HPLC chromatograms from leave and stem material  
                  A:  HPLC chromatogram for the summer sample (LF1A) 
                  B:  HPLC chromatogram for the stem sample (LF1C) 
                  C:  HPLC chromatogram for the storage sample (LF1B) 
Peaks indicate the following: 
a: sutherlandin A; b: sutherlandin D; c: sutherlandioside B; d: sutherlandioside D  
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Table 12:  Calculated concentrations of flavonoids and triterpenoids after HPLC analysis  
of leave material from different seasons, storage and stem samples of Lessertia 
frutescens. Concentrations were calculated according to peak areas. 
Season, 
storage, 
twigs/stem 
Sutherlandin 
A 
(n = 12) 
(mg/ml) 
Sutherlandin 
D 
(n = 12) 
(mg/ml) 
Sutherlandioside 
B 
(n = 12) 
(mg/ml) 
Sutherlandioside 
D 
(n = 12) 
(mg/ml) 
Summer 3.67 ± 0.01 4.10 ± 0.01  3.01 ± 0.03 5.82 ± 0.04 
Autumn 4.75 ± 0.04 6.37 ± 0.03 2.15 ± 0.03 3.33 ± 0.03 
Winter 4.23 ± 0.01 5.25 ± 0.01 2.89 ± 0.02 4.23 ± 0.02 
Spring 6.56 ± 0.02 6.08 ± 0.02 1.47 ± 0.01 2.50 ± 0.02 
Storage 4.07 ± 0.05 4.25 ± 0.02 2.82 ± 0.11 4.66 ± 0.03 
Twigs / stem 4.67 ± 0.08 3.31 ± 0.06 3.62 ± 0.01 5.80 ± 0.14 
 
3.5 Comparison of the flavonoid and triterpenoid levels 
The peak area was the parameter used in order to compare the levels of flavonoids 
(sutherlandin A and sutherlandin D) and triterpenoids (sutherlandioside B and 
sutherlandioside D).  Sets of results were established for each of the four 
constituents, representative of the four seasons, as well as for the stem and storage 
component of the study, collected during the summer season, and thus were 
compared to the summer season sample.      
 
The results of the chromatogram fingerprint peak area calculated concentrations 
for the seasonal samples ranged between 3.67 and 6.56 mg/ml for sutherlandin A, 
4.10 and 6.37 mg/ml for sutherlandin D, 1.47 and 3.01 mg/ml for sutherlandioside 
B, and 2.50 and 5.82 mg/ml for sutherlandioside D.  This indicated that the 
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highest seasonal concentrations for sutherlandin A were 6.56 ± 12.49 mg/ml, for 
sutherlandin D 6.37 ± 10.32 mg/ml, for sutherlandioside B 3.01 ± 7.19 mg/ml and 
for sutherlandioside D 5.82 ± 14.48 mg/ml.  
 
For the summer leaf and storage samples concentrations of the constituents ranged 
between 3.67 and 4.07 mg/ml for sutherlandin A, 4.10 and 4.25 mg/ml for 
sutherlandin D, 3.01 and 3.62 mg/ml for sutherlandioside B, and 4.66 and  
5.82 mg/ml for sutherlandioside D.  This indicated that the highest 
summer/storage concentrations for sutherlandin A were 4.07 ± 2.88 mg/ml, for 
sutherlandin D 4.25 ± 1.06 mg/ml, for sutherlandioside B 3.62 ± 0.39 mg/ml and 
for sutherlandioside D 5.82 ± 0.42 mg/ml. 
 
For the summer leaf and stem samples, the readings ranged between 3.67 and 4.67 
mg/ml for sutherlandin A, 3.31 and 4.10 mg/ml for sutherlandin D, 
2.82 and 3.01 mg/ml for sutherlandioside B, and 5.80 and 5.82 mg/ml for 
sutherlandioside D.  This indicated that the highest summer/stem concentrations 
for sutherlandin A were 4.67 ± 8.18 mg/ml, for sutherlandin D  
4.10 ± 4.81 mg/ml, for sutherlandioside B 3.01 ± 4.24 mg/ml and for 
sutherlandioside D was 5.82 ± 0.42 mg/ml. 
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3.5.1 Flavonoid and triterpenoid levels of the seasonal samples 
The season with the highest yield of sutherlandin A levels was spring 
(6.56 ± 12.49 mg/ml), followed by autumn (4.75 ± 12.49 mg/ml), winter 
(4.23 ± 12.49 mg/ml) and then summer (3.67 ± 12.49 mg/ml) having the lowest 
levels.  This accounted for 34.00 % of the total yield for sutherlandin A 
(Table 13).  The highest yield of sutherlandin D levels was autumn 
(6.37 ± 10.32 mg/ml), followed by spring (6.08 ± 10.32 mg/ml), winter 
(5.25 ± 10.32 mg/ml) and then summer (4.10 ± 10.32 mg/ml) having the lowest.  
This accounted for 29.22 % of the total yield for sutherlandin D 
(Table 13).  The highest yield of sutherlandioside B levels was summer 
(3.01 ± 7.19 mg/ml), followed by winter (2.89 ± 7.19 mg/ml), autumn 
(2.15 ± 7.19 mg/ml) and then spring (1.47 ± 7.19 mg/ml) having the lowest.  This 
accounted for 31.61 % of the total yield for sutherlandioside B (Table 13).  The 
highest yield of sutherlandioside D levels was summer (5.82 ± 14.48 mg/ml), 
followed by winter (4.23 ± 14.48 mg/ml), autumn (3.33 ± 14.48 mg/ml) and then 
spring (2.50 ± 14.48 mg/ml) having the lowest.  This accounted for 36.78 % of the 
total yield for sutherlandioside D (Table 13). 
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Table 13:  Percentage portion of the comparison of the four seasons relating to 
sutherlandin A, sutherlandin D, sutherlandioside B and sutherlandioside D.   
ᵃ The percentage portion of the total yield for a particular constituent across the four 
seasons.     
ᵇ The percentage proportion for a particular season from the total yield of sutherlandin A, 
sutherlandin D, sutherlandioside B and sutherlandioside D.  
Constituent Summer 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Autumn 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Winter 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Spring 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Sutherlandin A 3.67 
(19.13) 
(22.05)  
4.75 
(24.96) 
(28.73)  
4.23 
(21.91) 
(25.38) 
6.56  
(34.00) 
(39.33) 
Sutherlandin D 4.10 
(18.81) 
(24.59)  
6.37 
(29.22) 
(38.31) 
5.25  
(24.08) 
(31.56) 
6.08  
(27.89) 
(36.58) 
Sutherlandioside B 3.01 
(31.61) 
(18.17)  
2.15 
(22.59) 
(12.97) 
2.89  
(30.26) 
(17.49) 
1.47 
(15.54) 
(8.97) 
Sutherlandioside D 5.82  
(36.78) 
(35.19) 
3.33 
(20.91) 
(19.99) 
4.23  
(26.57) 
(25.57) 
2.50 
(15.74) 
(15.12) 
 
Independent t tests were performed to compare the concentrations averages of 
sutherlandin A found in summer, autumn, winter and spring, with one another.  
The same procedure was repeated for the comparison with regards to sutherlandin 
D, sutherlandioside B and sutherlandioside D.  The sutherlandin A concentration 
(6.56 ± 12.49 mg/ml) in material harvested in spring differs from all other seasons 
significantly (P < 0.0001).  For the sutherlandin D concentration 
(6.37 ± 10.32 mg/ml) in material harvested in autumn differs from all other 
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seasons significantly (P < 0.0001).  For the sutherlandioside B concentration 
(3.01 ± 7.19 mg/ml) in material harvested in summer differs from all other 
seasons significantly (P < 0.0001).  For the sutherlandioside D concentration 
(5.82 ± 14.48 mg/ml) in material harvested in summer differs from all other 
seasons significantly (P < 0.0001).  The seasonal variations for the four 
constituents, sutherlandin A, sutherlandin D, sutherlandioside B and 
sutherlandioside D are presented in Figures 21 to 24.   
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Figure 21:  Concentrations of sutherlandin A in leaf material of summer, autumn, winter 
and spring.  The sutherlandin A concentration (6.56 ± 12.49 mg/ml) harvested in spring is 
the highest and differs from all other seasons significantly (P<0.0001).   
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Figure 22:  Concentrations of sutherlandin D in leaf material of summer, autumn, winter 
and spring.  The sutherlandin D concentration (6.37 ± 10.32 mg/ml) harvested in autumn 
is the highest and differs from all other seasons significantly (P<0.0001).   
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Figure 23:  Concentrations of sutherlandioside B in leaf material of summer, autumn, 
winter and spring.  The sutherlandioside B concentration (3.01 ± 7.19 mg/ml) harvested 
in summer is the highest and differs from all other seasons significantly (P<0.0001).   
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Figure 24:  Concentrations of sutherlandioside D in leaf material of summer, autumn, 
winter and spring.  The sutherlandioside D concentration (5.82 ± 14.48 mg/ml) harvested 
in summer is the highest and differs from all other seasons significantly (P<0.0001).   
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3.5.2 Flavonoid and triterpenoid levels of the storage samples 
For the comparison of the levels of flavonoids and triterpenoids in the summer 
leaf material and storage samples, the highest yield of sutherlandin A levels was 
for that of the storage sample (4.07 ± 2.88 mg/ml) and then summer 
(3.67 ± 2.88 mg/ml) having the lowest levels.  The storage sample accounted for 
52.60 % of the total yield for sutherlandin A (Table 14).  The highest yield of 
sutherlandin D levels was that of the storage sample (4.25 ± 1.06 mg/ml) and then 
summer (4.10 ± 1.06 mg/ml) having the lowest.  The storage sample accounted 
for 50.89 % of the total yield for sutherlandin D (Table 14).  The highest yield of 
sutherlandioside B levels was summer (3.01 ± 0.39 mg/ml) and then storage   
(2.82 ± 0.39 mg/ml) having the lowest.  The summer sample accounted for 50.83 
% of the total yield for sutherlandioside B (Table 14).  The highest yield of 
sutherlandioside D levels was summer (5.82 ± 0.42 mg/ml) and then storage  
(4.66 ± 0.42 mg/ml) having the lowest.  The summer sample accounted for 
55.65 % of the total yield for sutherlandioside D (Table 14). 
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Table 14:  Percentage portion of the comparison of the summer leaf sample to that of the 
storage sample, relating to sutherlandin A, sutherlandin D, sutherlandioside B and 
sutherlandioside D.   
ᵃ The percentage portion of the total yield for a particular constituent.     
ᵇ The percentage proportion from the total yield of sutherlandin A, sutherlandin D, 
sutherlandioside B and sutherlandioside D.  
Constituent Summer 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Storage (1 year) 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Sutherlandin A 3.67 
(47.40) 
(22.05)  
4.07  
(52.60) 
(25.61) 
Sutherlandin D 4.10 
(49.11) 
(24.60)  
4.25  
(50.89) 
(26.67) 
Sutherlandioside B 3.01 
(50.83) 
(18.16)  
2.82  
(49.17) 
(18.38) 
Sutherlandioside D 5.82  
(55.65) 
(35.19) 
4.66  
(44.35) 
(29.34) 
 
 
Concentration averages of sutherlandin A found in summer leaf samples were 
compared with that of the storage sample.  The same procedure was repeated for 
the comparison with regards to sutherlandin D, sutherlandioside B and 
sutherlandioside D.  The sutherlandin A concentration (4.07 ± 2.88 mg/ml) of the 
storage sample was higher than that of the summer leaf sample (3.67 ± 2.88 
mg/ml), which was a significant difference (P < 0.0001).  The sutherlandin  
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D concentration (4.25 ± 1.06 mg/ml) of the storage sample was significantly 
(P < 0.0001) higher than that of the summer leaf sample (4.10 ± 1.06 mg/ml).  For 
the sutherlandioside B concentration (2.82 ± 0.39 mg/ml) of the storage sample 
was significantly (P < 0.0001) higher than that of the summer leaf sample 
(3.01 ± 0.39 mg/ml).  For the sutherlandioside D concentration (5.82 ± 0.42 
mg/ml) of the summer leaf sample was significantly (P < 0.0001) higher than that 
of the storage sample (4.66 ± 0.42 mg/ml).  The variations for the four 
constituents, sutherlandin A, sutherlandin D, sutherlandioside B and 
sutherlandioside D are presented in Figures 25 to 28.   
 
3.5.3 Flavonoid and triterpenoid levels of the stem samples 
For the comparison of the level of flavonoids and triterpenoids in the summer leaf 
and stem samples, the highest yield of sutherlandin A levels were obtained in the 
stem material (4.67 ± 8.18 mg/ml) compared to leaves harvested in summer 
(3.67 ± 8.18 mg/ml).  This difference is highly significant (P < 0.0001).  The stem 
sample accounted for 56.76 % of the total yield for sutherlandin A  
(Table 15).  The highest (P < 0.0001) yield of sutherlandin D levels was in 
summer samples (4.10 ± 4.81 mg/ml) compared to the stems (3.31 ± 4.81 mg/ml).  
The summer sample accounted for 54.49 % of the total yield for sutherlandin D 
(Table 15).  The highest yield of sutherlandioside B levels were measured in 
stems (3.62 ± 4.24 mg/ml), while leaves harvested in summer (3.01 ± 4.24 mg/ml) 
having the lowest (P < 0.0001).  The stem sample accounted for 54.48 % of the 
total yield for sutherlandioside B (Table 15).  The highest 
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(P < 0.0001) yield of sutherlandioside D levels was found in the summer leaf 
sample (5.82 ± 0.42 mg/ml) compared to the stem samples (5.80 ± 0.42 mg/ml).  
The summer leaf sample accounted for 50.25 % of the total yield for 
sutherlandioside D (Table 15).         
 
Table 15:  Percentage portion of the comparison of the summer leaf sample to that of the 
stem sample, relating to sutherlandin A, sutherlandin D, sutherlandioside B and 
sutherlandioside D.  
ᵃ The percentage portion of the total yield for a particular constituent.     
ᵇ The percentage proportion from the total yield of sutherlandin A, sutherlandin D, 
sutherlandioside B and sutherlandioside D.  
Constituent Leaves (summer) 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Stem (summer) 
(mg/ml) 
ᵃ (%) 
ᵇ (%) 
Sutherlandin A 3.67 
(43.24) 
(22.05)  
4.67  
(56.76) 
(27.11) 
Sutherlandin D 4.10 
(54.49) 
(24.59)  
3.31  
(45.51) 
(19.24) 
Sutherlandioside B 3.01 
(45.52) 
(18.17)  
3.62  
(54.48) 
(20.36) 
Sutherlandioside D 5.82  
(50.25) 
(35.19) 
5.80  
(49.75) 
(33.29) 
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Concentration averages of sutherlandin A found in summer leaf sample were 
compared with those of the stem samples.  The same procedure was repeated for 
the comparison with regards to sutherlandin D, sutherlandioside B and 
sutherlandioside D.  The sutherlandin A concentration (4.67 ± 8.18 mg/ml) of the 
stem sample were significantly higher (P < 0.0001) than that of the summer leaf 
sample (3.67 ± 8.18 mg/ml).  The sutherlandin D concentration (4.10 ± 4.81 
mg/ml) of the summer leaf sample showed significantly (P < 0.0001) higher 
values compared to the stem sample (3.31 ± 4.81 mg/ml).  Similar results were 
obtained for sutherlandioside B (summer leaf: 3.01 ± 4.24 mg/ml versus 
stem: 3.62 ± 4.24 mg/ml) and sutherlandioside D (summer leaf: 5.82 ± 0.42 
mg/ml versus stem: 5.80 ± 0.42 mg/ml), which was of significant difference 
(P < 0.0001).  The variations for the four constituents, sutherlandin A, 
sutherlandin D, sutherlandioside B and sutherlandioside D are presented in 
Figures 25 to 28.   
 
When comparing the flavonoid and triterpenoid concentrations in the stems with 
those of stored leaves results reveal significantly higher levels of sutherlandin A 
(stem: 4.67 ± 8.18 mg/ml; storage: 4.07 ± 2.88 mg/ml) and D 
(stem: 3.31 ± 4.81 mg/ml; storage: 4.25 ± 1.06 mg/ml), which was of significant 
difference (P < 0.0001).  In contrast, the effect of storage on the sutherlandioside 
B (stem: 3.62 ± 4.24 mg/ml; storage: 2.82 ± 0.39 mg/ml; 
P < 0.0001) and D (stem: 5.80 ± 0.42 mg/ml; storage: 4.66 ± 0.42 mg/ml; 
P < 0.0001) had the opposite effect (Figures 25 to 28). 
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Figure 25:  Concentrations of sutherlandin A in the summer, stem and storage samples.  
The sutherlandin A concentration (4.67 ± 8.18 mg/ml) from the stem sample was the 
highest, compared to that of the summer sample, which was of significant difference 
(P<0.0001).  The sutherlandin A concentration (4.07 ± 2.88 mg/ml) from the storage 
sample was the highest, compared to that of the summer sample, which was of significant 
difference (P<0.0001).   
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Figure 26:  Concentrations of sutherlandin D in the summer, stem and storage samples.  
The sutherlandin D concentration (4.10 ± 4.81 mg/ml) from the summer sample was the 
highest, compared to that of the stem sample, which was of significant difference 
(P<0.0001).  The sutherlandin D concentration (4.25 ± 1.06 mg/ml) from the storage 
sample was the highest, compared to that of the summer sample, which was of significant 
difference (P<0.0001).   
 
0 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
3.5 
4.0 
4.5 
Summer                Stem                  Store 
C
o
n
ce
n
tr
at
io
n
 (
m
g
/m
l)
 
P<0.0001 
P<0.0001 P<0.0001  
 
 
 
77 
 
 
Figure 27:  Concentrations of sutherlandioside B in the summer, stem and storage 
samples.  The sutherlandioside B concentration (3.62 ± 4.24 mg/ml) from the stem 
sample was the highest, compared to that of the summer sample, which was of significant 
difference (P<0.0001).  The sutherlandioside B concentration (2.82 ± 0.39 mg/ml) from 
the storage sample was the highest, compared to that of the summer sample, which was of 
significant difference (P<0.0001).   
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Figure 28:  Concentrations of sutherlandioside D in the summer, stem and storage 
samples.  The sutherlandioside D concentration (5.82 ± 0.42 mg/ml) from the summer 
leaf sample was the highest, compared to that of the stem sample, which was of 
significant difference (P<0.0001).  The sutherlandioside D concentration (5.82 ± 0.42 
mg/ml) from the summer sample was the highest, compared to that of the storage sample, 
which was of significant difference (P<0.0001).   
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CHAPTER 4 
 
DISCUSSION 
 
 
4.1 Overview 
The aim of this study was to investigate what impact, if any, the duration of 
storage and a particular season of harvest would have on the flavonoid and 
triterpenoid compounds levels of Lessertia frutescens.  In addition, the summer 
sample was used to compare the results from the leaf material, with that of the 
stem.  Three objectives were needing to be addressed, 1) to investigate storage 
variation of Lessertia frutescens leaves by comparing the results obtained from 
the HPLC analysis of the flavonoids and triterpenoids, 2) to investigate seasonal 
variation of Lessertia frutescens leaves by comparing the results obtained from 
the HPLC analysis of the flavonoids and triterpenoids, and 3) to investigate leaf 
and stem variation of Lessertia frutescens by comparing the results obtained from 
the HPLC analysis of the flavonoids and triterpenoids. 
 
What impact would the duration in storage have on the levels of flavonoids or 
triterpenoids, and would the summer season sample indicate a higher level of the 
above mentioned biomarkers, compared to the other three seasons?  There was 
mixed opinion from the suppliers and retailers of products containing Lessertia 
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frutescens, as to which part of the plant would have a higher concentration of 
biologically active constituents, the majority said the leaves (personal 
information).  According to traditional use, the parts of Lessertia frutescens used 
for its medicinal properties, had always been the leaves, along with the bits of 
stalks and stems, as reported by van Wyk et al. (1997), Moshe (1998), and Van 
Wyk and Albrecht (2008).     
 
The comparison of the four seasonal samples (LF1A, LF2, LF3 and LF4), the 
summer leaf (LF1A) sample with the storage sample (LF1B), and the summer leaf 
sample (LF1A) with the stem sample (LF1C) indicated some expected and some 
unexpected results with regard to the hypotheses of this study.  The expectation 
was that for the four seasonal samples, the spring sample would yield the highest 
levels of chemical constituents, while the storage sample would yield the same 
level of constituents as that of the summer leaf sample, and finally that the leaf 
sample would yield the same levels of constituents as that of the stem sample.  
  
4.2 Comparison of seasonal samples 
While for the comparison of the four seasonal samples the results did indicate that 
the spring sample yielded the highest levels of sutherlandin A, it was the autumn 
sample that yielded the highest levels of sutherlandin D, and the summer samples 
for sutherlandioside B and sutherlandioside D.  
 
 
 
 
 
81 
 
Previous studies have reported variations in secondary metabolites depending on 
the season and time of harvest.  Jerkovic et al. (2001) demonstrated that although 
Origanum vulgare (oregano, wild majoram) samples were harvested from the 
same geographical location, the different seasons had an effect on the qualitative 
and quantitative composition of the essential oils, with only a negligible amount 
of quality loss after one year in storage.  However, efficacy of medicinal plants 
relies on the selection of the correct chemotype.  In a study carried out on 
Withania somnifera (ashwaganda), which has three chemotypes, it was noticed 
that differences varied depending on genotype, time of collection and the 
environment (Joshi et al., 2004).  A study on Bacopa monneri (brahami), reported 
a higher level of the active constituent bacoside A, from September to March and 
then for the month of June (Mathur et al., 2002).  Active constituents and efficacy 
vary according to the season or time that medicinal plants are harvested (Singh, 
2008).  In the case of Lessertia frutescens the seasonal variations are in 
accordance with literature concerning seasonal harvesting in relation to other plant 
species.  
 
The molecular formula of the two flavonoid glycosides, sutherlandin A 
(C32H36O20) and sutherlandin D (C32H36O19) both have the ester 3-hydroxy-3-
methylglutaroyl (HMG) moiety attached at C-6 (Fu et al., 2010).  The 
esterification at the glucosyl unit may lead to shift changes for C-5 and C-6.  The 
authors thus refer to the two flavonols, sutherlandin A as the aglycone, quercetin 
and sutherlandin D as the aglycone, kaempferol.  Although two flavonoids have 
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two different sugar moiety‟s attached, namely β-D-xylospyranose and 
β-D-glucose, quercetin and kaempferol differ in that the latter has an extra 
hydroxyl group.  Thus, it is clear that both sutherlandin A and sutherlandin D are 
from the same biosynthetic pathway, in common with naturally occurring 
polyphenolics bearing hydroxyls on the same aromatic ring system.  It could be 
speculated that that both sutherlandin A and sutherlandin D would oxidize with 
time, in the case of sutherlandin A to ortho-quinone and sutherlandin D to 
meta-quinone. 
 
The naturally occurring cycloartane glycosides with C-1 functionality group, 
sutherlandioside B (C36H60O10) and sutherlandioside D (C36H58O9) are very 
similar (Fu et al., 2008).   The biosynthetic pathway considerations suggest that 
the presence of the C-1 ketone in sutherlandioside B may facilitate the ring 
opening of the strained cyclopropane system.  It could be speculated that that both 
sutherlandioside B and sutherlandioside D undergo changes though dehydration at 
the drying stage already, combined with possible oxidizing while being stored 
over time.   
 
The quality of a medicinal plant is preserved by drying.  However, different 
species of plants have varying sensitivities to temperature (Rocha et al., 2011).  
Thus, by drying the fresh plant material to remove water, the concept of an 
enzymatic or microbial activity on the plant material, is basically ruled out.  
Consideration is made that all moisture is never entirely removed and although the 
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European Pharmacopedia (2005) does indicate maximum final moisture allowed 
to still be regarded as preserved, in the case of Lessertia frutescens this has not 
been listed.  
 
In the case of this study, all fresh Lessertia frutescens material was dried and 
immediately placed into glass containers and sealed to prevent any moisture or 
insects from entering the material during storage.  As the container with the dried 
material was placed into a dark cupboard the chance of degradation due to light 
was excluded as well.  Harbourne et al. (2009) studied the impact of drying 
Filependula ulmaria (meadowsweet) at 30°C and 70°C, the higher temperature 
resulted in a reduction of the plants flavonoid content.  The Lessertia frutescens 
material was dried at 35°C in an attempt to preserve the flavonoid content in light 
of the literature but acknowledge that no fresh sample was analysed for grounds 
of a comparison.   
 
In this study, the seasons of spring and autumn yielded the highest levels of 
flavonoids, while the summer season yielded the highest levels of the 
triterpenoids.  In light of the literature (Yanivie and Palevitch, 1982; Bopana and 
Saxena, 2007) concerning the impact the environment has on secondary 
metabolite production, it is speculated that the milder weather gives rise to the 
production of the flavonoids, sutherlandin A in Spring, followed by sutherlandin 
D in autumn, while in the case of much warmer weather the production of the 
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triterpenoids, sutherlandioside B and sutherlandioside D is required by Lessertia 
frutescens plants. 
 
4.3 Comparison of summer and storage samples 
Comparing the freshly prepared summer sample with the sample that was in 
storage for one year, the stored sample indicated the highest levels of sutherlandin 
A and sutherlandin D.  However, in the case of the freshly prepared summer 
sample, sutherlandioside B and sutherlandioside D indicated higher levels. 
 
Previous studies (Houba et al., 1995; Fennell et al., 2004a) have reported that 
secondary metabolites can be influenced by duration in storage, depending on the 
type of constituent.  Harborne and Williams (2000) and Joshi et al. (2004) report 
that the factors effecting the chemical profile of plants are divided into two 
groups, intrinsic (genetics) and extrinsic (cultivation, drying, storage) factors.  
According to Bottcher et al. (2011) the extrinsic factor, post-harvest storage is 
important as well.  In their work, the post-harvest storage of Matricaria recutita 
(chamomile) resulted in deterioration of the external quality of Matricaria flowers 
in a much shorter time than other flowers.  The higher the temperature, the more 
deterioration occurred.  Plant quality was maintained as good quality for up to 70 
hours after harvest, if the plant material was stored at 10°C.  To maintain 
maximum essential oils, the drying temperature of 35°C was selected (Bottcher et 
al., 2011).   
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Eloff (1999) discovered that despite herbarium specimens (Helichrysum 
pedunculatum) being 100 years old, the plant material still displayed antibacterial 
activity.  In line with these observations, Houba et al. (1995) reported no 
significant change in chemical composition in plant material (lucerne, barley and 
tea leaves) after 10-20 years of storage.  Eucomis autumnalis (pineapple flower) 
was monitored for its anti-inflammatory activity in a study carried out by Taylor 
and Van Staden (2001) that monitored the impact of age, season and growth 
conditions on the anti-inflammatory activity of this plant.  The authors reported 
differences depending on time of harvest in relation to before or after growing 
season, with the highest activity just before dormancy.  In addition, mature plant 
material indicated higher anti-inflammatory activity than that of younger plants.   
 
The pharmacological activity of medicinal plants could be influenced by storage 
but this was noted as being species-and temperature-dependent (Fennell et al., 
2004a).  When comparing the ethanolic extract of fresh and dried leaves of 
Sisphonochilus aethiopicus (wild ginger) for COX-1 inhibition and antibacterial 
activity against Staphylococcus aureus, a significant decrease of inhibition, by as 
much as 49% in the dried extract was obvious (Fennell et al., 2004a).   
 
Factors that influence degradation of plant material are chemical breakdown, 
decomposition, microbial and insect attack (Fennell et al., 2004a).  The biological 
activity of the plant material will be influenced by chemical changes and these 
reactions are in return influenced by a number of factors, enzymes being one of 
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them (Fennell et al., 2004a).  In the case of storage of essential oils of Zingiber 
officinalis (ginger), Sukamura (1987) reported that the chemical composition of 
certain oils increased, while other oils decreased drastically, even to undetectable 
amounts.  Stafford et al. (2005) reported that the anti-bacterial constituents 
remained stable while being stored or in some cases changed into compounds that 
demonstrated more activity.  This would definitely have an impact on the efficacy 
of the medicinal plant material.  In terms of sustainability, storage of certain plant 
materials could be extended, making it financially more viable and therefore 
fewer plants being harvested from the wild (Griggs et al., 2001).   
 
In the case of this study, the storage variations indicated an increase in the case of 
the flavonoids, sutherlandin A and sutherlandin D but no increase in the case of 
the triterpenoids, sutherlandioside B and sutherlandioside D.  Nishikikawa et al. 
(2005) bring attention to the essential roles sugars play in the biochemical 
metabolism in plant material especially during post-harvest of perishable 
commodities.    Lessertia frutescens would not have such high sugar content, but 
the sugar substituents would be higher in the flavonoids than in the triterpenpoids.    
 
4.4 Comparison of the leaf and stem samples 
For the leaves versus stem comparison, the leaf sample yielded the highest levels 
of sutherlandin D, while the stems yielded the highest levels of sutherlandin A, 
sutherlandioside B and sutherlandioside D. 
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Research carried out on Glycine max (soybean) in order to establish the 
occurrence of pinitol in the developing soybean seed, revealed interesting 
information concerning levels of constituents during developmental stages (Kuo 
et al., 1997).  The leaves, petioles, stems, roots, nodules, bean and seeds were 
used.  Concentrations of pinitol, myo-inisitol and raffinose saccharids were 
regularly effected during seed development.  Myo-inositol increased during seed 
fill then decreased rapidly as seeds accumulated raffinose saccharids (soluble 
carbohydrates), whereas when pinitol increased, myo-inisitol levels decreased 
(Kuo et al., 1997).  The authors suggested that the possible occurrence of pinitol 
in leaves of plants resulted as a response to water or salinity stress.  It was noted 
that as the axis of leaves turned yellow, due to temperature stress, the pinitol 
levels increased (Guo and Oosterhuis, 1995).  The research thus indicates that 
secondary metabolites may vary throughout the various parts of a plant.  
  
Plant developmental stages influenced the secondary metabolite production and 
Guo and Oosterhuis (1995) found that secondary metabolites produced as a form 
of defence were more concentrated and diverse when plants were young, 
decreasing with age.  These authors suggested that young plants were more 
appealing to herbivores than older plants.  Letchamo (1998) reported that 
alkalmide composition in Echinacea palla varied qualitatively and quantitatively 
throughout the growth and developmental stages.  Alkamide levels decreased after 
34-58 days in the roots of the control plants, while ketoalkynes levels increased as 
the roots aged (Binns et al. 2001).   
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In the case of Lessertia frutescens, the leaf versus stem comparison reflects 
typically as to the literature (Van Wyk and Gericke, 2000; Van Wyk and Wink, 
2004) that traditional healers used both the leaf and stem material as medicine.  
As to why there are mostly higher levels of the flavonoids and triterpenoids in the 
stem material compared to the leaves, could be considered from the perspective 
that production of the constituents being monitored are higher in the older 
material (stem) of the plant, than the leaves.  Or that the drying temperature on 
softer material like the leaves contributed to increased degradation of the 
constituents compared to harder material of the stems.  
    
With regards to efficacy of Lessertia frutescens, Tai et al. (2004) demonstrated 
the anti-proliferative activities of Sutherlandia in an in vitro study carried out on 
human breast and leukemia tumor cell lines.  Results indicated a difference in 
antiproliferative effect on breast and leukemia cell lines, with the activity being 
higher in the breast cell lines.  With different cell lines being arrested at different 
phases, it was suggested that this may be due to different constituents having an 
effect.  The authors do mention that there is uncertainty as to exactly which 
components are responsible for this anti-proliferative effect.   
 
Crooks and Rosenthal (1994) have been investigating L-canavanine as an 
important constituent with regards to pancreatic cancer.  It is noted that 
L-canavanine changes to canavanine-containing proteins, which disrupts RNA 
and DNA synthesis, in vitro (Bence et al., 2002).  Sutherlandia is a member of the 
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leguminous family, which are able to produce and store L-canavanine as a means 
of protection (Rosenthal, 1997).  
  
All these studies indicate that the efficacy of medicinal plants is far more 
complicated than merely administering the correct therapeutic dosage and the 
plant material attributed to a particular disease.  The extrinsic factors influence 
plants in very specific ways depending on the species, leading to the 
development/accumulation of secondary metabolites that become crucial for the 
survival of the plants.  These secondary metabolite pools seem to be able to 
change depending on the situation the plant is experiencing; for instance 
depending on whether a plant is starting to produce seed or the particular season 
of the year that the plant is growing in.  Albrecht (2008) suggests that the 
Sutherlandia species seems to be subject to continuous variations of the secondary 
metabolites like the flavonoids and triterpenoids, which contributes to the 
capability of tumour-cell death.  When looking at efficacy of medicinal plants in 
relation to human beings, one would need to integrate this knowledge with the 
findings related to the extrinsic factors effecting plant secondary metabolite 
production in order to be able really understand the offering plants can make in 
benefiting health in human beings. 
 
The results obtained from this study did reflect similarly to what much of the 
literature regarding seasonal, storage and parts of medicinal plants being used has 
been indicating.  No doubt that the matter pertaining to seasonal harvesting, 
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storage and parts being used is more diversified and complex than expected, one 
would need to consider a much broader range of parameters in order to be more 
specific.  Therefore, this study can be seen as a starting point to further 
investigations of these aspects, which are of clinical, pharmacological and 
economic importance. Thus, a number of limitations of this study are 
acknowledged.   
 
4.5 Scope and limitations 
Regardless of the influence seasonal harvesting and the duration of time in storage 
may have on the pharmacological activity of medicinal plants, not much research 
has been done in this field worldwide and especially in Southern Africa (Griggs et 
al., 2001; Fennell et al., 2004a., Springfield et al., 2005).  It is for this reason that 
a considerable part of the literature review of this study was devoted to the 
seasonal and storage time influences on constituents of plant material other than 
Lessertia frutescens.  This was done in order to establish a base upon which 
information relevant to Lessertia frutescens and eventually other indigenous 
medicinal plants could be created.  This study shows the importance of seasonal 
changes.  It shows the changes during storage.  Thus, it might be used as a 
guideline for Lessertia frutescens.  However, the study has limitations, these 
being: 
 
The geographical context, as these samples were grown in Stellenbosch and the 
preference to a particular climatic environment may result in variations in 
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constituent levels.  Geographical deviation often indicates biological activity 
variations (Taylor and Van Staden, 2001; Shale et al., 2005; Buwa and Van 
Staden, 2007). 
   
Other factors like altitude, competition, soil type and nutrients, moisture stress, 
rain, temperature, microclimate, light and growth stages were not considered for 
the purpose of this study.  The impact of environmental factors and their effect on 
the secondary metabolites are known to have an influence on the quality of 
medicinal plants (Fennell et al., 2004a; Ncube et al., 2012).    
 
This was a commercially farmed crop, which was irrigated and organically 
composted.  Plant material harvested from the wild could possibly indicate 
different levels of the secondary metabolites.  Bopana and Saxena (2007) indicate 
that factors like ecological, environmental and genetics differences result in 
variations of biologically active constituents between plants harvested in the wild 
compared to commercially harvest plants. 
 
The Lessertia frutescens plants used in this study were all two years of age, what 
would the results be from younger or older plant material?  In addition, the 
samples were collected at 10h00 in the morning on each selected seasonal 
collection date; would a late afternoon collection time have yielded a different 
result? A phenomenon most likely for essential oils since they are located on the 
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surface but less likely for solvent extracted materials but possibly worth additional 
investigation.  
 
Post-harvest temperature was not monitored as the plant material was dried within 
a couple of hours of harvesting, but in the hotter months chemical degradation of 
the plant material could be increased.  Physiological post-harvest responses are 
considered very important in being able to prevent additional deterioration of the 
plant material before processing (Bottcher et al., 1999; Bottcher et al., 2001; 
Bottcher et al., 2003). 
 
Other constituents not used as markers in this study that could possibly reveal 
different data are alanine, arginine, aspartic acid, asparagine, leucine, phenylanine, 
proline, tryptophan, L-canavine and γ-aminobutyric acid (GABA).  Various 
constituents (e.g. L-canavanine for certain cancers and pinitol in cases of diabetes) 
found in Lessertia frutescens have been reported and considered important in the 
efficacy of the plant (Bell, 1958; Snyders, 1965; Viljoen, 1969; Brummerhof, 
1969; Bell et al., 1978; Moshe, 1998; Tai et al., 2004; VanWyk and Albrecht, 
2008; Fu et al., 2008; Avula et al., 2010). 
 
The duration of storage was selected as one year, while a longer period could or 
may not have a different outcome.  Houba et al. (1995) concluded that plant 
material could be stored for long periods of time with no changes to the 
constituent levels or composition. 
 
 
 
 
93 
 
Furthermore, one would have to consider that the findings of this study based are 
on an ethanolic extract.  However, what would the results be from an aqueous 
extract of Lessertia frutescens?  Aqueous extracts would closely resemble the 
traditional way of preparation of the medicine for oral ingestion.  Infusions and 
decoctions were the most common dosage forms recorded under traditional 
practices (Van Wyk, 2008).  
 
4.6 Conclusion and recommendations 
With the renewed interest in medicinal plants, increased demand on the world 
markets and reliance for healthcare needs of traditional medicines, comes a great 
opportunity for trade and commerce (Joshi et al., 2004, Fennell et al., 2004a).  
Consumers, manufacturers, growers, researchers, amongst others, are able to 
benefit from the many opportunities resulting from the acquiring of new 
knowledge and understanding of the diverse plant world (Binns et al., 2001).  The 
authors express the importance of identifying chemotypes as a means of possible 
prediction of phytochemical content.  In order to benefit from the range of herbal 
medicines, pharmaceuticals, phytochemicals, nutraceuticals, and cosmetics 
require correct identification, quality assurance, standardization and quality 
control in order to contribute towards safety and efficacy (Joshi et al., 2004).   
 
Databases would play a vital role in establishing drug diversity, development and 
therapeutics (Joshi et al., 2004).  Van Wyk (1996) proposes a multidisciplinary 
approach that would involve the fields of biosystematics, ethanobotany, 
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horticulture, organic chemistry and pharmacology as means to best practice for 
expanding commercial opportunities.  Van Wyk (1996) also suggests that the 
biological understanding of the species be the starting point, which would include 
the areas of chemical variation, genetics, phylogeny, reproductive biology and 
taxonomy.   
 
The plant world offers an abundance of chemical constituents that are produced as 
secondary metabolites as a direct relation to the environment they are in (Dey and 
Harborne, 1989).  Ncube et al. (2012) considers the evidence of environment and 
genetics on the production of secondary metabolites, as a means of questioning 
the possibility of being able to manipulate the environment, in so doing increasing 
the production of the secondary metabolites desired for commercial markets.  
Plants are unable to avoid interaction with the environment, these external factors 
impact on the metabolic processes of the plant, effecting plant development, 
growth rates and thus the secondary metabolite production (Lommen et al., 2008).   
Chemical constituents in medicinal plants may act individually, additively or in 
synergy to improve health (Ncube, et al., 2012).  Van Wyk and Wink (2004) 
highlight the importance of considering that even small changes in the chemistry 
of a plant, would have an impact on the pharmacological activity.  The above 
gives a greater insight into the complexities of the plant world and secondary 
metabolite production.  By understanding these diverse factors it may contribute 
considerably to the development of commercial products.     
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From the results of this study, one can conclude that the production of secondary 
metabolites are influenced by environmental factors like seasonal harvesting, as 
indicated by the variation in the chemical constituent composition of Lessertia 
frutescens depending on the season collected in.  Moreover,  that the storage of 
Lessertia frutescens for a period of one year under the conditions described, did 
appear to result in an increase of two of the four constituents being monitored.   
As well as the slight variations in the chemical constituents in the leaves and stem 
material of Lessertia frutescens.  Finally, besides the seasonal influence, storage 
and part (leaves or stem) of Lessertia frutescens being used, the type of chemical 
constituent being monitored was also important in the consideration of this study.   
 
The results did raise questions, which further research would need to answer in 
order to establish scientific qualitative information for Lessertia frutescens to 
ensure quality, safety and efficacy of this traditional medicinal plant.  Once the 
relevant data are established, commercially cultivated plant material could replace 
wild harvested plant material, to ensure sustainability as the supply and demand 
for traditional medicinal plant material increases.  
 
In conclusion, the results of this study provides initial data on the impact duration 
of storage and seasonal harvesting have on selected biomarker levels for Lessertia 
frutescens, and this should be useful in further research for developing a complete 
profile for Lessertia frutescens as a useful traditional medicine.  In addition, it 
could provide a foundation upon which similar research could be conducted on 
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other commonly used traditional medicinal plants, in order to establish quality 
assurance, safety and efficacy.  Thus, these data are of importance for clinical, 
pharmacological and economic aspects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
REFERENCES 
 
 
Amabeoku, G.J., Eagles, P., Scott, G., Mayeng, I., Springfield, E., 2001. 
Analgesic and antipyretic effects of Dodonaea angustifolia and Salvia 
africana-lutea. Journal of Ethanopharmacology 75, 117-124. 
Ashok, K., Amit, A., Sujatha, M., Murali, B., Anand, M.S., 2002. Effect of aging 
on andrographolide content in Andrographis paniculata. Journal of 
Natural remedies 2, 2. 
Avula, B., Wang, Y-H., Smillie, T.J., Fu, X., Li, X.C., Mabusela, W., Syce, J., 
Johnson, Q., Folk, W., Khan, I.A., 2010. Quantitative determination of 
flavonoids and cycloartanol glycosides from aerial parts of Sutherlandia 
frutescens (L) R.BR. by using LC-UV/ELD methods and confirmation by 
using LC-MS method. Journal of Pharmaceutical and Biomedical Analysis 
52, 173-180. 
Badi, H.N., Yazdani, D., Ali, S.M., Nasari, F., 2003. Effects of spacing and 
harvesting time on herbage yield and quality/quantity of oil in thyme, 
Thymus vulgaris L. Institute of Medicinal plants and Natural Products 
Research, Iranian Academic Centre for Education, Culture and Research. 
Industrial Crops and Products 19, 231-236. 
 
 
 
 
98 
 
Bates, S.H., Jones. R.B., Bailey, C.J., 2000. Insulin-like effect of pinitol. Journal 
of Pharmacology 130, 1944-1948. 
Bauer, R., Tittel, G., 1996. Quality assessment of herbal preparations as a 
precondition of pharmacological and clinical studies. Phytomedicine 2, 
193-198. 
Bell, E.A., 1958. Canavanine and related compounds in the Leguminsae. 
Biochemistry Journal 70, 617-619. 
Bell, E.A., Lackery, J.A., Polhill, R.M., 1978. Systematic significance of 
canavanine in Papilionoideae (Faboideae). Biochemical Systematics and 
Ecology 6, 201-212. 
Bence, A.K., Worthen, D.R., Adams, V.R., Crooks, P.A., 2002. The 
antiproliferative and immunotoxic effect of L-canavanine and L-canaline. 
Anti-Cancer Drugs 13, 313-320. 
Binns, S.E., Inparajah, I., Baum, B.R., Arnason, J.T., 2001. Methyl jasmonate 
increases reported alkamides and ketoalkene/ynes in Echinacea pallida 
(Asteraceae). Phytochemistry 3, 417-420. 
Binns, S.E., Arnason, J.T., Baum, B.R., 2002. Phytochemical variation within 
populations of Echinacea angustifolia (Asteraceae). Biochemical 
Systematics and Ecology 9, 837-854. 
Bone, K., 2003. A clinical guide to blending liquid herbs: herbal formulations for 
the individual patient. Churchill Livingstone, London. 
 
 
 
 
99 
 
Bopana, N., Saxena, S., 2007. Asparagus racemosus – ethanopharmacological 
evaluation and conservation needs. Journal of Ethanopharmacology 110, 
1-15.  
Bottcher, H., Gunther, I., Bauermann U., 1999. Physiological postharvest 
responses of marjoram (Majorana hortensis Moench). Postharvest Biology 
and Technology 15, 41-52. 
Bottcher, H., Gunther, I., Bauermann., Franke, R., Warnstorff, K., 2001. 
Physiological postharvest responses of Matricaria (Matricaria recutita L.) 
flowers. Postharvest Biology and Technology 22, 39-51. 
Bottcher, H., Gunther, I., Kabelitz, L., 2003. Physiological postharvest responses 
of Common Saint-John‟s wort herbs (Hypericum perforatum L.). 
Postharvest Biology and Technology 29, 342-350. 
Bown, D., 2002. The Royal Horticultural Society: Encyclopedia of Herbs and 
Their Uses. Dorling Kindersley Limited, London. 
British Herbal Pharmacopeia, 1923. Constable and Co. Ltd, London. 
British Herbal Pharmacopeia, 1983. British Herbal Medicine Association, 
Bournemouth, UK. 
British Pharmaceutical Codex, 1968. Pharmaceutical Press, London. 
Brummerhoff, S.W.D., 1969. Some constituents of Sutherlandia microphylla. 
D.Sc. Thesis. University of the Free State, Bloemfontein. 
 
 
 
 
100 
 
Burkhard, P.R., Burkhardt, K., Haenggeli, C., Landis, T., 1999. Plant induced 
seizures: Reappearance of an old problem. Journal of Neurology, 246, 
667-670. 
Buwa, L.V., Van Staden, J., 2007. Effects of collection time on the antimicrobial 
activities of Harpephyllum caffrum bark. South African Journal of Botany 
73, 242-247. 
Chevallier, A., 1996. The encyclopedia of medicinal plants. Dorling Kindersley, 
London. 
Court, W.A., Roy, R.C., Pocs, R., 1993. Effect of harvest date on the yield and 
quality of the essential oil of peppermint. Canadian Journal of Plant 
Science 73, 815-824 
Crooks, P.A., Rosenthal, G.A., 1994. Use of L-canavanine as a chemotherapeutic 
agent for the treatment of pancreatic cancer. United States Patent no. 
5,552, 440. 
Crouch, N., Symmonds, R., Spring, W., Diederichs, N. (Ed.), Commercialising 
Medicinal Plants – A Southern African Guide. Sun Press, Stellenbosch, 
97-142. 
Cunningham, A.B., 1993. African medicinal plants: setting priorities at the 
interface between conservation and primary healthcare. People and Plants 
Working Paper 1. UNESCO, Paris. 
 
 
 
 
101 
 
Cunningham, A.B., 1988. An investigation of the Herbal Medicine Trade in 
Natal/KwaZulu. Investigation Report 29, Institute for Natural Resources, 
South Africa. 
De Vasconcelos Silva, M.G., Craveiro, A.A., Matos, F.J.A., Machado, M.I.L., 
Alencar, J.W., 1999. Chemical variation during daytime of constituents of 
the essential oil of Ocimum gratissimum leaves. Fitoterapia 70, 32-34. 
Derita, M.G., Leiva, M.L., Zacchino, S.A., 2009. Influence of plant part, season of 
collection and content of the main constituent, on the antifungal properties 
of Polygonum acuminatum kunth, Journal of Ethnopharmacology, 124, 
377-383. 
Deswick, P.M., 1987. Medicinal Natural Products: A biosynthetic approach, 
Hoboken, NJ: John Wiley and Sons. 
Dey, P.M., Harborne, J.B., 1989. Methods in Plant Chemistry: Plant Phenolics, 
vol 1. Academic Press, New York.  
Dodd, A.N., Salathia, N., Hall, A., 2005. Plant circadian clocks increase 
photosynthesis, growth, survival, and competitive advantage. Science 309, 
630-633. 
El Ansari, M.A., Reddy, K.K., Sastry, K.N.S., Nayudamma, Y., 1971. 
Polyphenols of Mangifera indica. Phytochemistry 10, 2239-2241. 
 
 
 
 
102 
 
Eloff, J.N., 1999. Is it possible to use herbarium specimens to screen for 
antibacterial components in some plants. Journal of Ethnopharmacology 
67, 355-360.  
Emboden, W., 1997. Narcotic plants. Hallucinogens, stimulants, inebriants, and 
hypnotics, their origins and uses. Macmillan Publishing Co., Inc., Canada. 
EMEA, European agency for the evaluation of medicinal products (1994): ICH 
Quality Guideline. Q2A: Note for the guidance on validation of analytical 
methods: definitions and terminology. CPMP/ICH/281/95. 
EMEA, European agency for the evaluation of medicinal products (1996): ICH 
Quality Guideline. Q2B: Validation of analytical procedures: 
methodology. CPMP/ICH/381/95. 
European Pharmacopoeia, 2002a. Methods of analysis: Bitterness value. 2.8.15. 
European Directorate for the Quality of Medicines (EDQM) of the Council 
of Europe, Strasbourg, 2147. 
European Pharmacopoeia, 2002b. General Monographs: Loss on drying of 
extracts. 2.8.16. European Directorate for the Quality of Medicines 
(EDQM) of the Council of Europe, Strasbourg, 1667. 
European Pharmacopoeia, 2002d. General Monographs: Herbal teas. 2.8.16. 
European Directorate for the Quality of Medicines (EDQM) of the Council 
of Europe, Strasbourg, 1667. 
Evans, W.C., 1989. Trease and Evans‟ Pharmacognosy. Bailliere Tindall, London. 
 
 
 
 
103 
 
Farhat, G.N., Affara, N.I., Gali-Muhtasib, H.U., 2001. Seasonal changes in the 
composition of the essential oil extract of east Mediterranean sage (Salvia 
libanotica) and its toxicity in mice. Toxicon, 39, 1601-1605. 
Fell, A.F., Clark, B.J., Scott, H.P., 1994. Computer-aided strategies for archive 
retrieval and sensitivity enhancement in the identification of drugs by 
photodiode array detection in HPLC. Journal of Chromotography 316, 
423-440. 
Fennell, C.W., Light, M.E., Sparg, S.G., Stafford, G.I., Staden, J., 2004a. 
Assessing African medicinal plants efficacy and safety: Agricultural and 
storage practices. Journal of Ethnopharmacology 95, 113-121. 
Fennell, C.W., Light, M.E., Sparg, S.G., Stafford, G.I., Staden, J., 2004b. 
Assessing African medicinal plants efficacy and safety: Pharmacological 
screening and toxicity. Journal of Ethnopharmacology 94, 205-217. 
Fernandes, A.C., Cromarty, A.D., Albrecht, C., Van Rensberg, C.E., 2004. The 
antioxidant potential of Sutherlandia frutescens, Journal of 
Ethnopharmacology 95, 1-5. 
Fluck, H and Pharm M., 1955. The influence of climate on the active principles in 
medicinal plants. Journal of Pharmacology 7, 361-383. 
Foukaridis, G.N., Muntingh, G.L., Osuch, E., 1994. Application of diode 
detection for the identification of poisoning by traditional medicines. 
Journal of Ethnopharmacology 41, 135-146. 
 
 
 
 
104 
 
Freire, C.M.M., Marques, M.O.M., Costa, M., 2006. Effects of seasonal variation 
on the central nervous system activity of ocimum gratissimum L. essential 
oil. Journal of Ethnopharmacology 105, 161-166.  
Fu, X., Li, X-C., Smillie, T.J., Carvalho, P., Mabusela, W., Syce, J., Johnson, Q., 
Folk, W., Avery, M.A., Khan I.A., 2008. Cycloartane glycosides from 
Sutherlandia frutescens. Journal of Natural Products 71, 1749-1753. 
Fu, X., Li, X-C., Smillie, T.J., Carvalho, P., Mabusela, W., Syce, J., Johnson, Q., 
Folk, W., Avery, I.A., 2010. Flavonol glycosides from the South African 
medicinal plant Sutherlandia frutescens. Planta Medica 76, 178-181. 
Gericke, N., Albrecht, C.F., Van Wyk, B.-E., Mayeng, B., Mutwa, C., Hutchings, 
A., 2001. Sutherlandia frutescens, Australian Journal of Medicinal Herbs 
13, 9-15. 
Gericke, N., 2001. Diabetes and Sutherlandia, Sutherlandia Dot Org. Available 
from: http://www.sutherlandia.org/diabetes.html. 
Goldblatt, P. & Manning, J.C., 2000. Cape plants. A conspectus of the Cape flora 
of South Africa. Strelitzia 9. National Botanical Institute, Pretoria & 
Missouri Botanical Garden Press, Missouri. 
Guo, C. and Oosterhuis, D.M., 1995. Journal of Experimental Botany 46, 249. 
Govender, S., Du Plessis-Stoman, D., Downing, T.G., Van de Venter, M., 2006. 
Traditional herbal medicines: microbial contamination, consumer safety 
and the need for standards. South African Journal of Science 102, 253-255. 
 
 
 
 
105 
 
Green, M.H., 1988. (filed 25 Jan.). Method of treating viral infections with amino 
acid analogs. United States Patent no. 5,110-600. 
Griggs, J.K., Manandhar, N.P., Towers, G.H.N., Taylor, R.S.L., 2001. The effects 
of storage on the biological activity of medicinal plants from Nepal. 
Journal of Ethnopharmacology 77, 247-252. 
Gurib-Fakim, A., 2006. Medicinal plants: traditions of yesterday and drugs of 
tomorrow. Molecular Aspects of Medicine 27, 1-9. 
Harborne, J.B., Williams, C.A., 2000. Advances in flavonoid research since 1992. 
Phytochemistry 55, 481-504. 
Harris, D.C., 2003. Quantitative chemical analysis. W.H. Freeman and Company, 
England. 
Horst, B., Ingelborg, G., Lothar, K., 2003. Physiological postharvest responses of 
common Saint-John‟s Wort herb herbs (Hypericum perforatum L.). 
Postharvest Biology and Technology 29, 343-352. 
Houba, V.J.G., Novozamsky, I., Van der Lee, J.J., 1995. Influence of storage of 
plant samples on their chemical composition. The Science of the Total 
Environment 176, 73-79. 
Hutchings, A., Scott, A.H., Lewis, G., Cunningham, A., 1996. Zulu Medicinal 
Plants: An Inventory. University of Natal Press, Pietermaritzburg. 
Iwu, M.W., 1993. Handbook of African Medicinal Plants. CRC Press. 
 
 
 
 
106 
 
Jackson, W.P.U., 1990. Origins and meanings of names of South African plant 
genera. U.C.T. Printing Dept., Cape Town. 
Jagetia, G.C., Baliga, M.S., 2005. The effect of seasonal variation on the 
antineoplastic activity of Alstonia scholaris R. br. in HeLa cells. Journal of 
Ethnopharmacology 96, 37-42. 
Jerkovic, I., Mastelic, J., Milos, M., 2001. The impact of both season of collection 
and drying on the volatile constituents of Origanum vulgare L. ssp. Hirtum 
grown wild in Croatia. International Journal of Food Science and 
Technology 36, 649-654. 
Johnson, Q., Syce, J., Nell, H., Rudeen, K., Folk, W.R., 2007. A randomized, 
double-blind, placebo-controlled trial of Lessertia frutescens in healthy 
adults. PLoS Clinical Trials 2 (4), art. no. e16 (1-7). 
Joshi, K., Chavan, P., Warude, D., Patwardhan, B., 2004. Molecular markers in 
herbal drug technology. Current Science 87, 159-165. 
Kim, Y., Lounds-Singleton, A. J., Talcott, S. T., 2009. Antioxidant phytochemical 
and quality changes associated with hot water immersion treatment of 
mangos (Mangifera indica L). Food Chemistry 115, 989-993. 
Kuo, T.M., Lowell, C.A., Nelsen, T.C., 1997. Occurrence of pinitol in developing 
soybean seed tissues. Phytochemistry 45, 29-35. 
 
 
 
 
107 
 
 Lakshminarayana, S., Subhadra, N. V., Subramanyam, H., 1970. Some aspects of 
development physiology of mango fruit. Journal of Horticultural Science 
45, 133-142. 
Letchamo, W., Livesey, J., Arnason, J.T., Bergeron, C., Krutilina, V.S., 1998. 
Cichoric acid and isobutylamide content in Echinacea purpurea as 
influenced by flower developmental stages. New crops and new uses. 
Biodiversity and Agricultural Sustainability 1, 8-11. 
Lommen, W.J.M., Bouwmeester, H.J., Schenk, E., Verstappen, F.W.A., Elzinga, 
S., Struik, P.C., 2008. Modelling processes determining and limiting the 
production of secondary metabolites during crop growth: the example of 
antimalarial artemisinin produced in Artemisia annua. Acta Horticulture 
765, 87-94. 
Lopes, N.P., Kato, M.J., de Aguiar Andrade, E.H., Maia, J.G.S., Yoshida, M., 
1997. Circadian and seasonal variation in the essential oil from Virola 
surinamensis leaves. Phytochemistry 46, 689-693. 
Mander, M., Le Breton, G., 2006. Overview of the medicinal plants industry in 
Southern Africa. In: Diedrichs. N. (Ed), Commercialising Medicinal Plants 
– A Southern African Guide. Sun Press, Stellenbosch, pp 1-8. 
Manning, J., 2007. Photographic guide to the wildflowers of South Africa. Briza 
publications. South Africa. 
 
 
 
 
108 
 
Mathur, S.,Gupta M M., Ram, M., Sharma, S and Kumar, S., 2002. Herb yield 
and bacoside-A content of field grown Bacopa monnieri accessions. 
Journal of Herbs, Spices & Medicinal Plants 9, 11-18. 
McClung, C.R., 2006. Plant circadian rhythms. The Plant Cell 18, 792-803. 
McGimpsey, J.A., Douglas, M.H., Van Klink, J.W., Beauregard, D.A., Perry, 
N.B., 1994. Seasonal variation in Essential oil yield and composition from 
naturalized Thymus vulgaris L. in New Zealand. Flavour Fragrance 9, 347-
352. 
Mc Intyre, K.L., Harris, C.S., Saleem, A., 2009. Seasonal phytochemical variation 
in lowbush blueberry (Vaccinium angustifolium). Planta Medica 75, 286-
292. 
Medical Research Council and National Research Foundation of South Africa., 
2002. A toxicity study of Sutherlandia leaf powder (Sutherlandia 
microphylla) consumption. Final Report 2002. 
Mills, E., Cooper, C., Seely, D., Kanfer, I., 2005. African herbal medicines in the 
treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence 
and pharmacology, Nutrition Journal 4, 1-6. 
Mills, S., Bone, K., 2000. Principles and Practice of Phytotherapy: Modern Herbal 
Medicine. Churchill Livingstone, London. 
Mills, S., 1991. The Essential Book of Herbal Medicine. Arkana, Penguin books, 
London. 
 
 
 
 
109 
 
Mitra, S. K., Baldwin, E. A., 1997. Postharvest physiology storage of tropical and 
subtropical fruit. CAB International, New York. 
Moraes, L.A.S., Facananali, R., Marques, M.O.M., Ming, L.C., Meireles, M.A.A., 
2002. Phytochemical characterization of essential oil from Ocimum selloi. 
Annals of the Brazilian Academy of Sciences 74, 183-186. 
Moteetee, A., Van Wyk. B-E., 2007. The concept of Musa-pelo and the medicinal 
use of shrubby legumes (Fabaceae) in Lesotho, Bothalia 37, 75-77.  
Moshe, D., 1998. A biosystematic study of the genus Sutherlandia R.Br. 
(Fabaceae, Galegeae). M.Sc. Thesis (Botany). University of Johannesburg. 
Moshe, D., Van Der Bank, H., Van Der Bank, M., Van Wyk, B.-E., 1998. Lack of 
genetic differentiation between 19 populations from seven taxa of 
Sutherlandia Tribe: Galegeae, Fabaceae, Biochemical Systematics and 
Ecology 26, 595-609.  
Muller-Riebau, F.J., Berger, B.M., Yegen, O., Cakir, C., 1997. Seasonal 
variations in the chemical composition of essential oils of selected 
aromatic plants growing wild in Turkey. Journal of Food and Agricultural 
Chemistry 45, 4821-4825. 
Murch, S.J., Haq, K., Rupasinghe, H.P.V., Saxena, P.K., 2003. Nickel 
contamination affects growth and secondary metabolite composition of St 
John‟s wort (Hypericum perforatum L.). Environmental and Experimental 
Botany 49, 251-257. 
 
 
 
 
110 
 
Niacker, K., Cukrowska, E., McCarthy, T.S., 2003. Acid mining drainage arising 
from gold mining activity in Johannesburg, South Africa and environs. 
Environmental Pollution 122, 29-40. 
Nishikawa, F., Iwama., T., Kato, M., Hyodo, H., Ikoma, Y., Yano, M., 2005. 
Effect of sugars on ethylene synthesis and responsiveness in harvested 
broccoli florets. Postharvest Biology Technology 36, 157-165. 
Ncube, B., Finnie, J.F., Van Staden, J., 2012. Quality from the field: The impact 
of environmental factors as quality determinants in medicinal plants. South 
African Journal of Botany 82, 11-20. 
Ojewole, J.A.O., 2004. Analgesic, anti-inflammatory and hypoglycemic effects of 
Sutherlandia frutescens R.Br. (variety incana E. Mey.) (Fabaceae) shoot 
aqueous extract, Methods and Findings in Experimental and Clinical 
Pharmacology 26, 409-416.  
Ojewole, J.A.O., 2008. Anticonvulsant property of Sutherlandia frutescens R.Br. 
(variety incana E. MEY.) (Fanaceae) shoot aqueous extract, Brain 
Research Bulletin 75, 126-132. 
Ortega, A., 2003. A new role for GABA: inhibition of tumor cell migration. 
Trends in Pharmacological Science 24, 151-154. 
Ostlund, R.E., Sherman, W.R., 1996. Pinitol and derivatives thereof for the 
treatment of metabolic disorders. United States Patent no. 5,8827,896. 
 
 
 
 
111 
 
Palmer, E., 1985. The South African herbal, Tafelberg Publishers, Cape Town, 
South Africa. 
Phillips, E.P., Dyer, R.A., 1934. The genus Sutherlandia R.Br, Revista 
Sudamericana de Botanica 1, 69-90. 
Pitarevic, I., Kustrak, D., Kuftinec, J., Blazevic, N., 1985. Influence of ecological 
factors on the content and composition of the essential oil in Salvia 
officinalis. Essential oils and aromatic plants. The Netherlands, Junk 
Publishers.  
Powrie, L., 2004. Common names of Karoo plants. Strelitzia 16. National 
Botanical Institute, Pretoria.  
Pujol, J., 1990. Natur Africa: The Herbalists Handbook. Jean Pujol Natural 
Healers Foundation, Durban. 
Rai, V., Khatoon, S., Bisht, S.S., Mehrotra., S, 2005. Effect of cadmium on 
growth, ultramorphology of leaf and secondary metabolites of Phyllanthus 
amarus Schum and Thonn. Chemosphere 61, 1644-1650. 
Ramakrishnappa, K., 2002. Impact of cultivation and gathering of medicinal 
plants on biodiversity: case studies from India. In: FAO (Ed.). Biodiversity 
and the Ecosystem Approach in Agriculture, Forestry and Fisheries. 
Satellite Event on the Occasion of the Ninth Regular Session of the 
Commission on Genetic Resources for Food and Agriculture, Rome. 
 
 
 
 
112 
 
Roberts, M., 1990. Indigenous Healing Plants. Southern Book Publishers, 
Halfway House, South Africa. 
Rood, B., 1994. Uit die Veldapteek. Tafelberg Publishers, Cape Town, South 
Africa (Translation of title: “Out of the field-pharmacy”). 
Rosenthal, G.A., 1997. L-canaline; a potent antimetabolite and anti-cancer agent 
from leguminous plants. Life Science 60, 1635-1641. 
Roychoudhury, A.N., Starke, M.F., 2006. Partitioning and mobility of trace 
metals in the Blesbokspruit: impact assessment of dewartering of mine 
waters in the East Rand, South Africa. Applied Geochemistry 21, 1044-
1063. 
Sakamura, F., 1987. Changes in volatile constituents of Zingiber officinale 
rhizomes during storage and cultivation. Phytochemistry 26, 2207-2212. 
Santos-Gomes, P.C., Fernandes-Ferreira, F., 2001. Organ-and season-dependant 
variation in the essential oil composition of Salvia officinalis L. cultivated 
at two different sites. Journal of Food and Agricultural Chemistry 49, 
2908-2916. 
SATMERG, 1999. http://www.sahealthinfo.org/traditionalmeds/htm. 
Scott, G., Springfield, E.P., Coldrey, N., 2004. A pharmacognostical study of 26 
South African plant species used as traditional medicines. Pharmacutical 
Biology 42, 186-213. 
 
 
 
 
113 
 
Seier, J.V., Mdhluli, M., Dhansay, M.A., Loza, J., Laubscher, R., 2002. A toxicity 
study of Sutherlandia leaf powder (Sutherlandia microphylla) 
consumption. Final report: April 2002. Medical Research Council of South 
Africa and National Research Foundation. 
Shale, T.L., Stirk, W.A., Van Staden, J., 2004. Effect of storage on antibacterial 
and COX-1 anti-inflammatory activity of tree plants used as traditional 
medicines in Lesotho. South African Journal of Botany. 
Sia, C., 2004. Spotlight on ethnomedicine: usability of Sutherlandia frutescens in 
the treatment of diabetes. The Review of Diabetic Studies 1, 145-149. 
Singh, A., 2008. A note on variation of active principles in Indian medicinal 
plants and TIM formulations. Ethnobotanical Leaflets 12, 603-603. 
Smith, C.A., 1966. Common Names of South African Plants. Botanical Survey 
Memoir No. 35. Government Printer, Pretoria, South Africa. 
Snyders, J.H., 1965. Chemical investigation of Sutherlandia microphylla Burch. 
M.Sc. Thesis. University of the Free State, Bloemfontein. 
Southwell, I.A., Bourke, C.A., 2001. Seasonal variation in hypericin content of 
Hypericum perforatum L. (St John‟s wort) Phytochemistry 56, 437-441. 
Sparg, S.G., Jager, A.K., Magwa, M.L., Van Staden, J., 2005. Cultivating the 
medicinal plant Merwilla natalensis as a crop-a small scale farming 
approach. Outlook on Agriculture 34, 116-120. 
 
 
 
 
114 
 
Springfield, E.P., Eagles, P.K.F., Scott, G., 2005. Quality assessment of South 
African herbal medicines by means of HPLC fingerprinting. Journal of 
Ethnopharmacology 101, 75-83. 
Stafford, G.I., Jager, A.K., Van Staden, J., 2005. Effect of storage on the chemical 
composition and biological activity of several popular South African 
medicinal plants. Journal of Ethnopharmacology 97, 107-115. 
Stander, B. A., Marais, S., Steynberg, T.J., Theron, D., Joubert, F., Albrecht, C., 
Joubert, A.M., 2007. Influence of Sutherlandia frutescens extracts on cell 
numbers, morphology and gene expression in MCF-7 cells. Journal of 
Ethnopharmacology 112, 312-318. 
Stewart, M.J., Steenkamp, V., Zuckerman, M., 1998. The toxicology of African 
herbal medicines. Therapeutic Drug Monitoring 20, 510-516. 
Street, R.A., Kulkarni, M.G., Stirk, W.A., Southway, C., Staden, J., 2008. 
Variation in heavy metals and essential elements in South African 
medicinal plants obtained from street markets. Food additives and 
Contaminants 25, 953-960. 
Swaffar, D.S.,1995. Combination therapy with 5-fluoroouracil and L-canavanine: 
in-vitro and in-vivo studies. Anticancer Drugs 6, 586-593. 
Tai, J., Cheung, S., Chan, E., Hasman, D., 2004. In vitro culture studies of 
Sutherlandia on human tumor cell lines. Journal of Ethnopharmacology 
93, 9-14. 
 
 
 
 
115 
 
Taylor, J.L.S., Van Staden, J., 2001. COX-1 inhibitory activity in extracts from 
Eucomis L‟Herit. Species. Journal of Ethanopharmacology 75, 257-265. 
Taylor, J.L.S., Elgorashi, E.E., Maes, A., Van Gorp, U., DeKimpe, N., Van 
Staden, J., Verscaeve, L., 2003. Investigating the safety of plants used in 
South African traditional medicine: testing for genotoxicity in the 
micronucleus and alkaline comet assays. Environmental and Molecular 
Mutagenesis 42, 144-154. 
Usai, M., Marchetti, M., Foddai, M., Del Caro, A., Desogus, R., Sanna, I., Piga, 
A., 2010. Influence of different stabilizing operations and storage time on 
the composition of essential oil of thyme (Thymus vulgaris L.) and 
rosemary (Rosmarinus officinalis L.). LWT – Food Science and 
Technology, 1-6. 
Umezu, T., Sakata, A., Ito, H., 2001. Ambulation-promoting effect of peppermint 
oil and identification of its active constituents. Pharmacology 
Biochemistry and Behavior 69, 383-390. 
Van Staden, J., 1999. Medicinal plants in Southern Africa: ulilization, 
sustainability, conservation – can we change the mindsets? Outlook on 
Agriculture 28, 75-76. 
Van Wyk, B.-E., van Oudtshoorn, B., Gericke, N., 1997. Medicinal Plants of 
South Africa. Briza, Pretoria, South Africa. 
 
 
 
 
116 
 
Van Wyk, B.-E., and Gericke, N., 2000. People‟s Plants. A Guide to the Useful 
Plants of Southern Africa. Briza, Pretoria, South Africa. 
Van Wyk, B.-E., 2006. A broad review of commercially important Southern 
African medicinal plants. Journal of Ethnopharmacology 119, 342-355.  
Van Wyk, B.-E., Wink, M., 2004. Medicinal plants of the World. Briza, Pretoria, 
South Africa. 
Van Wyk, B.-E., Albrecht, C., 2008. A review of the taxonomy, ethnobotany, 
chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). 
Journal of Ethnopharmacology 119, 620-629. 
Van Wyk, B.-E., 2008. A broad review of commercially important southern 
African medicinal plants. Journal of Ethnopharmacology 119, 342-355. 
Viljoen, P.T., 1969. The oxidation of pinitol and partial identification of a 
triterpene glycoside from Sutherlandia microphylla Burch. M.Sc. Thesis. 
University of the Free State, Bloemfontein. 
Vogel, H.G., 1991. Similarities between various systems of traditional medicine. 
Considerations for the future of ethnopharmacology. Journal of 
Ethnopharmacology 35, 179-190. 
Website: http:// www.sutherlandia.org 
WHO, 1998a. Regulatory Situation of Herbal Medicines: A Worldwide Review. 
World Health Organization, Geneva. 
 
 
 
 
117 
 
WHO, 1998b. Quality Control Methods for Medicinal Plant Material. World 
Health Organization, Geneva. 
WHO, 2000. General Guidelines for Methodologies on Research and Evaluation 
of Traditional Medicines. World Health Organization, Geneva. 
WHO, Press Release, 2002. Who launches the first global strategy on traditional 
and alternative medicine. WHO 38. 
WHO, 2003. Guidelines on Good Agricultural and Collection Practices (GACP) 
for Medicinal Plants. Geneva. 
Xaba, P.M.A., Notten, A., 2003. Kistenbosch Botanical Garden. 
Yanivie, Z., Palevitch, D., 1982. Effects of drought on secondary metabolites of 
medicinal and aromatic plants. In: Atal, C.K., Kapur, B.M. Cultivation and 
Utilization of Medicinal Plant, Regional Research Laboratory council of 
Scientific & Industrial Research, Jammu-Tawi, pp. 1-12. 
 
 
 
 
